Query 018169
Match_columns 360
No_of_seqs 133 out of 310
Neff 7.3
Searched_HMMs 46136
Date Fri Mar 29 06:43:34 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/018169.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/018169hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG2864 Nuclear division RFT1 100.0 2.1E-71 4.5E-76 536.8 36.8 345 7-356 5-365 (530)
2 PF04506 Rft-1: Rft protein; 100.0 2.4E-70 5.1E-75 560.2 30.2 342 12-357 3-386 (549)
3 PRK10459 colanic acid exporter 100.0 1.3E-26 2.9E-31 235.7 30.7 322 7-354 2-324 (492)
4 COG2244 RfbX Membrane protein 99.8 7.3E-18 1.6E-22 170.8 24.6 326 7-354 3-331 (480)
5 PRK15099 O-antigen translocase 99.8 2.1E-16 4.5E-21 157.8 28.0 320 11-354 2-331 (416)
6 TIGR02900 spore_V_B stage V sp 99.8 2.4E-16 5.2E-21 159.7 28.5 329 13-347 2-346 (488)
7 PF01943 Polysacc_synt: Polysa 99.7 2E-15 4.3E-20 139.9 27.2 269 13-300 2-272 (273)
8 TIGR01695 mviN integral membra 99.7 2.3E-14 5E-19 145.8 30.9 326 11-349 1-336 (502)
9 PF13440 Polysacc_synt_3: Poly 99.7 5.9E-15 1.3E-19 135.8 24.2 248 28-300 2-251 (251)
10 TIGR00797 matE putative efflux 99.2 1.6E-08 3.5E-13 97.6 29.0 314 20-345 3-324 (342)
11 PF03023 MVIN: MviN-like prote 98.7 5.6E-05 1.2E-09 76.8 30.1 216 128-355 100-318 (451)
12 PRK09575 vmrA multidrug efflux 98.5 0.00032 6.8E-09 71.2 29.6 317 7-344 9-342 (453)
13 PRK01766 multidrug efflux prot 98.5 0.00026 5.7E-09 71.5 28.6 321 12-344 14-346 (456)
14 PRK00187 multidrug efflux prot 98.4 0.00052 1.1E-08 69.9 29.7 318 10-347 10-346 (464)
15 COG0534 NorM Na+-driven multid 98.0 0.0094 2E-07 60.8 28.2 320 8-348 15-352 (455)
16 PRK10367 DNA-damage-inducible 97.9 0.023 4.9E-07 57.6 29.4 317 10-344 9-339 (441)
17 PRK10189 MATE family multidrug 97.4 0.18 4E-06 51.6 30.3 312 13-344 32-366 (478)
18 COG0728 MviN Uncharacterized m 97.1 0.44 9.5E-06 49.4 33.1 324 8-347 5-343 (518)
19 PRK10459 colanic acid exporter 95.1 4 8.6E-05 41.5 20.7 174 13-197 210-391 (492)
20 COG2244 RfbX Membrane protein 94.7 4.7 0.0001 40.7 20.1 163 12-179 215-384 (480)
21 PRK15099 O-antigen translocase 94.5 5.5 0.00012 39.6 24.7 45 11-55 216-260 (416)
22 TIGR00797 matE putative efflux 94.0 0.17 3.6E-06 48.6 7.2 101 241-347 2-102 (342)
23 PRK01766 multidrug efflux prot 93.7 0.26 5.6E-06 49.8 8.4 111 231-346 11-121 (456)
24 PRK09575 vmrA multidrug efflux 91.9 0.95 2E-05 45.9 9.5 112 230-345 10-121 (453)
25 TIGR02900 spore_V_B stage V sp 91.7 16 0.00035 36.7 21.2 68 127-196 352-419 (488)
26 PF01554 MatE: MatE; InterPro 91.7 0.14 3.1E-06 43.5 2.7 99 241-344 2-100 (162)
27 PRK10189 MATE family multidrug 89.6 0.87 1.9E-05 46.7 6.9 113 229-346 26-138 (478)
28 PRK10367 DNA-damage-inducible 89.6 1.9 4.2E-05 43.6 9.2 110 231-344 8-117 (441)
29 TIGR01695 mviN integral membra 87.8 33 0.00072 34.7 21.9 159 12-176 225-397 (502)
30 PF01554 MatE: MatE; InterPro 86.1 1.4 3.1E-05 37.2 5.0 83 20-108 3-89 (162)
31 PRK00187 multidrug efflux prot 84.6 5 0.00011 40.8 9.0 110 232-348 10-119 (464)
32 PF07260 ANKH: Progressive ank 81.0 58 0.0013 31.9 20.0 211 31-266 32-269 (345)
33 COG0534 NorM Na+-driven multid 72.8 19 0.0004 36.7 8.8 113 230-347 15-127 (455)
34 PF13440 Polysacc_synt_3: Poly 64.7 7.7 0.00017 34.9 3.7 37 257-293 9-45 (251)
35 PF01943 Polysacc_synt: Polysa 60.9 27 0.00059 31.4 6.7 63 238-300 5-67 (273)
36 PF14667 Polysacc_synt_C: Poly 48.3 1.5E+02 0.0032 24.2 13.1 65 129-197 2-66 (146)
37 COG0728 MviN Uncharacterized m 47.7 89 0.0019 32.6 8.5 115 233-350 8-124 (518)
38 PF06123 CreD: Inner membrane 38.3 4.3E+02 0.0093 27.0 11.5 60 5-65 287-347 (430)
39 PF12794 MscS_TM: Mechanosensi 36.5 4.2E+02 0.0091 25.9 13.3 30 127-156 232-261 (340)
40 COG3628 Phage baseplate assemb 35.3 16 0.00034 30.0 0.6 24 272-295 38-61 (116)
41 COG4452 CreD Inner membrane pr 22.6 7.3E+02 0.016 25.0 9.5 56 10-65 292-347 (443)
42 PRK11715 inner membrane protei 22.2 8.6E+02 0.019 24.9 10.8 60 5-65 293-353 (436)
No 1
>KOG2864 consensus Nuclear division RFT1 protein [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.1e-71 Score=536.77 Aligned_cols=345 Identities=35% Similarity=0.513 Sum_probs=314.9
Q ss_pred CcchhhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHHHHHhcccCCCCccchh
Q 018169 7 DHSTSLSRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRRACMRADIKCDGASREE 86 (360)
Q Consensus 7 ~~~~~~~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~a~lr~~~~~~~~~~~~ 86 (360)
++-.+..+|+..++.+|+.+|++||++|++++|+++||++|++++++|++++|++|+|||++|+|++|.++..+|
T Consensus 5 ~vL~ss~~ga~~~i~~Q~~~RiiTF~lN~~liR~~s~~v~gi~nvrl~lL~sTiLFlsREair~A~l~~gs~~~d----- 79 (530)
T KOG2864|consen 5 SVLESSFSGAVFSIRGQLLARIITFALNALLIRFLSPEVLGIVNVRLELLQSTILFLSREAIRLAELRIGSEPAD----- 79 (530)
T ss_pred HHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHcChhheehhHHHHHHHHHHHHHhhHHHHHHHhccCCCCCCc-----
Confidence 344567899999999999999999999999999999999999999999999999999999999999998776643
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccc----cCCchhhHHHHHHHHHHHHhhhhhHHHHHHHhHhHHHHHHHH
Q 018169 87 NAAKLLKVAWLTLPLGIFITIGACFFVLWWQGLS----YSNPYAQAIFINGFACVLELLAEPLYILSQNLLLLRLRLVVE 162 (360)
Q Consensus 87 ~~~~~~n~awl~i~~g~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~~~E 162 (360)
+|.+..|+.|++.|++..+++.++.+|++|.... +.++|..++.++++|+++|+++||+++++|..+.++.|+.+|
T Consensus 80 ~~te~~n~~wlS~~L~~~i~~~~i~~wl~~~~s~d~i~~~p~y~~~I~~~~~S~vvELlsEp~~iv~Q~~~~~~~~~i~e 159 (530)
T KOG2864|consen 80 TWTEFINLLWLSVPLQTAINVACIYFWLGFLSSSDEISYSPLYAFAIFIIGLSIVVELLSEPLYIVSQCGLKVQLRAIAE 159 (530)
T ss_pred cHHHHHHhhhhhhhHHHHHHHHHHHHHHHHhhccchhhcCchHhHHHHHHHHHHHHHHhcccHHHHHHHHHHHHHHHHHh
Confidence 6888999999999999999999888888776332 556678999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHHHHHHHHHH-HHHhhc-------ccccCccCCCcccC--cccccH
Q 018169 163 TVATFSRCFTMCILIVKQYEMEKGIVFALSQVAYAASLFLGYWG-YFLLFG-------AFKTSDLFPFRLGN--MMSYDK 232 (360)
Q Consensus 163 ~~a~~~~~~~~v~l~~~~~~~~a~~~fa~gql~~s~~~~~~y~~-~~~~~~-------~~~~~~~~P~r~~~--~~~~~~ 232 (360)
+.+.++||++.++..+..++.|++.+||+||++|+++++++|.. |+...+ ..+.++++|+..++ ...||+
T Consensus 160 ~l~~~v~~i~~fa~lv~~~~~~~l~~FAlaql~~~itl~l~y~~~Yf~~~~s~~~~~~~~r~Sdllpk~~~n~~~~ffd~ 239 (530)
T KOG2864|consen 160 GLATIVKCIVLFAGLVMGPNMYALLAFALAQLAYAITLLLCYYWFYFYIRGSIPETEPFSRFSDLLPKVSENERGIFFDN 239 (530)
T ss_pred HHHHHHHHHHHHHHHHhcCchhHHHHHHHHHHHhhHHHHHHHHHHHHHHcCCcccccchhhhhhhccCCCCCCccccccH
Confidence 99999999999999999999899999999999999999886644 444443 23456899998766 678999
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhceeeeEecc--CCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhhh
Q 018169 233 QLANMCTLFTFQSFRKLLLQEGEKLVLVWLD--TPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKSK 310 (360)
Q Consensus 233 ~ll~~~~~~~~qsi~k~lltegDk~vl~~~~--~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~~ 310 (360)
|+.++.+.++.|+++||++|||||++|+... +..|||+|++++||||+++|++|+||||++|.+|+|..+.+++|+.+
T Consensus 240 d~~~~~~s~~~Qs~lKqlLTeGdkyvmt~~~~ls~~~QgvYd~v~n~GSLlaR~iF~PIEEss~~~FA~~ls~~~qe~~k 319 (530)
T KOG2864|consen 240 DLLKLTKSFTFQSFLKQLLTEGDKYVMTFTELLSFGDQGVYDLVSNYGSLLARLIFRPIEESSYIYFARLLSRDNQENVK 319 (530)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccceeEeeeccCCcchhhHHHHHHhhhhHHHHHHhChhHHHHHHHHHHHhhccchhhHH
Confidence 9999999999999999999999999999665 67799999999999999999999999999999999999999888888
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhcccChHHHHHHHhcCCcCccchh
Q 018169 311 KIGNSLAEALKLVLLIGMFFIELKFSLPIYEFNFVVKGICLTISVI 356 (360)
Q Consensus 311 ~~~~~l~~~L~~~~~lgl~~~~~G~~~s~~ll~~llG~kW~~~~~~ 356 (360)
++.+++.+++|++.++|+++++|||+||+.++++..|+||.+++.-
T Consensus 320 ~a~~vL~~lLklv~~igli~~~FG~~YS~~vL~lygG~kwss~~~~ 365 (530)
T KOG2864|consen 320 KAVDVLSNLLKLVIYIGLIFITFGPAYSYVVLLLYGGSKWSSGGGS 365 (530)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhcCccccHHHHHHHcCccccCCCch
Confidence 9999999999999999999999999999999999999999998753
No 2
>PF04506 Rft-1: Rft protein; InterPro: IPR007594 Asymmetric lipid distribution is a fundamental characteristic of biological lipid bilayers, one such axample is the translocation of the Man5GlcNAc2-PP-Dol intermediate from the cytosolic side of the ER membrane to the lumen before the completion of the biosynthesis of Glc3Man9GlcNAc2-PP-Dol []. RFT1 encodes an evolutionarily conserved protein required for this translocation.; GO: 0005319 lipid transporter activity, 0006869 lipid transport, 0016021 integral to membrane
Probab=100.00 E-value=2.4e-70 Score=560.16 Aligned_cols=342 Identities=34% Similarity=0.543 Sum_probs=288.3
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHHHHHhcccCCCCccchhhHHHH
Q 018169 12 LSRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRRACMRADIKCDGASREENAAKL 91 (360)
Q Consensus 12 ~~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~a~lr~~~~~~~~~~~~~~~~~ 91 (360)
-.+|++++++.|+++|++||++|++++|+++||+||++++++|++++|++|+||||+|+||+|+++++ .++.+|++.
T Consensus 3 s~~gas~li~lQl~sRllTFvlN~lllR~lsp~ilGi~nv~LeLl~sTILFlSRE~fR~A~lR~~~~~---~~~~~~~~~ 79 (549)
T PF04506_consen 3 SAKGASFLILLQLLSRLLTFVLNQLLLRFLSPEILGIANVQLELLYSTILFLSREAFRRACLRQPSSS---IDKSNWAQS 79 (549)
T ss_pred hhhhHHHHHHHHHHHHHHHHHHHHHHHHhCCHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCCCcc---cCcccHHHh
Confidence 46899999999999999999999999999999999999999999999999999999999999998776 223356778
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHH------------Hhhccc-----cCCch-hhHHHHHHHHHHHHhhhhhHHHHHHHhH
Q 018169 92 LKVAWLTLPLGIFITIGACFFVL------------WWQGLS-----YSNPY-AQAIFINGFACVLELLAEPLYILSQNLL 153 (360)
Q Consensus 92 ~n~awl~i~~g~~~~~~~~~~~~------------~~~~~~-----~~~~~-~~~~~~~~ls~iie~l~eP~~~~~qr~l 153 (360)
.|..|.+.|++.+++..++.+++ .|.... ..+|| ..++.++++++++|+++||+|++.|.++
T Consensus 80 ~n~~wls~~lq~vvn~~~~~I~l~~igi~~~~~~~~~~~~~~~~~~~~~p~~~~~v~l~~~s~~iELlsEP~~il~Q~~l 159 (549)
T PF04506_consen 80 INLLWLSVPLQAVVNLICSYIWLAWIGIPLSILLSQYQYASISNAFVIEPYFEPSVFLYGLSAFIELLSEPLYILAQQML 159 (549)
T ss_pred hhcccccCcchhheehhHHHHhHhhccccHHHHHHHHHhhcchhhHHhhhhHHHHHHHHHHHHHHHHhhhHHHHHHHHHh
Confidence 88888877777666653333322 111111 12466 4789999999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHhc--cC-----------chhHHHHHHHHHHHHHHHHHHHHHHHHhhcccccCccC
Q 018169 154 LLRLRLVVETVATFSRCFTMCILIVKQ--YE-----------MEKGIVFALSQVAYAASLFLGYWGYFLLFGAFKTSDLF 220 (360)
Q Consensus 154 ~~~~r~~~E~~a~~~~~~~~v~l~~~~--~~-----------~~a~~~fa~gql~~s~~~~~~y~~~~~~~~~~~~~~~~ 220 (360)
+++.|+++|+.+.++||+++++++++. .+ ..++++|+.||++|+++.+.+|..... ...++.++.+
T Consensus 160 ~~~~Rv~~E~~A~~~k~i~t~~~v~~~~~~~~~~~~~~~~~~~~~~l~Falgq~~ys~~l~~~y~~~~~-~~~~~~s~~l 238 (549)
T PF04506_consen 160 FFKLRVKAESLAVFAKCIVTFALVVLAERSGYGFFYFLSGQEGLAILAFALGQLAYSITLFFCYYWMYF-FPFKSFSDLL 238 (549)
T ss_pred hhheeeEechHHHHHHHHHHHHHHHHHHhcccceeeeeccchhHHHHHHHHHHHHHHHHHHhhHHhhcc-Ccccchhhcc
Confidence 999999999999999999999987554 11 135689999999999988877754322 1122334566
Q ss_pred CCccc---CcccccHHHHHHHHHHHHHHHHHHHHhhhceeeeEe--ccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHH
Q 018169 221 PFRLG---NMMSYDKQLANMCTLFTFQSFRKLLLQEGEKLVLVW--LDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYA 295 (360)
Q Consensus 221 P~r~~---~~~~~~~~ll~~~~~~~~qsi~k~lltegDk~vl~~--~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~ 295 (360)
|+... +...+|++++++.+.++.||++||+||||||++|+. ++|++|||+|++++|||||+||++||||||++|.
T Consensus 239 p~i~~~~~~~~~fd~~~l~l~~~~~~Qsi~K~lLTEGdk~vl~~~~~~t~~~QGvY~lv~N~GSLvaR~lF~PiEEs~~~ 318 (549)
T PF04506_consen 239 PKISSGNPKSYYFDRDLLSLTWSFFFQSILKHLLTEGDKLVLSFFNLLTFEDQGVYALVSNYGSLVARLLFQPIEESSRL 318 (549)
T ss_pred ccccccccccccCCHHHHHHHHHHHHHHHHHHHHhhCCeEEEEeeccCCHHHhhHHHHHhhHHHHHHHHHhCcHHHHHHH
Confidence 65433 356799999999999999999999999999999999 9999999999999999999999999999999999
Q ss_pred HHHhhhcCCCchh------hhHHHHHHHHHHHHHHHHHHHHHHhcccChHHHHHHHhcCCcCccchhc
Q 018169 296 TFARSASGQYPQK------SKKIGNSLAEALKLVLLIGMFFIELKFSLPIYEFNFVVKGICLTISVIG 357 (360)
Q Consensus 296 ~Fs~~~~~~~~~~------~~~~~~~l~~~L~~~~~lgl~~~~~G~~~s~~ll~~llG~kW~~~~~~~ 357 (360)
+|||+.+++++++ .++..+++..++|.+.++|+++++|||+||+.++++++|+||.++++..
T Consensus 319 ~Fsk~l~~~~~~~~~~~~~~~~~~~~l~~ll~~~~~~gl~~~~fG~~~s~~lL~~~~g~~w~~~~~~~ 386 (549)
T PF04506_consen 319 YFSKLLSRDNSKKKQPQESLKQAANVLSNLLKFYLYLGLVIVAFGPPYSPLLLRLLGGSRWSSTSAPS 386 (549)
T ss_pred HHHHHhcccCchhhccchhHHHHHHHHHHHHHHHHHHHHHHHHhChhhHHHHHHHHhhhcccCCCchH
Confidence 9999988754433 3567789999999999999999999999999999999999999988743
No 3
>PRK10459 colanic acid exporter; Provisional
Probab=99.96 E-value=1.3e-26 Score=235.69 Aligned_cols=322 Identities=12% Similarity=0.067 Sum_probs=244.1
Q ss_pred CcchhhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHHHHHhcccCCCCccchh
Q 018169 7 DHSTSLSRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRRACMRADIKCDGASREE 86 (360)
Q Consensus 7 ~~~~~~~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~a~lr~~~~~~~~~~~~ 86 (360)
|+++|+.+|+.|+.+.++.+++++|+.+.+++|+|+||+||+++....++ +....+++.|+..+++|.+++++
T Consensus 2 ~~~~~~~~g~~w~~~~~~~~~~~~~i~~~ilaR~L~p~~~G~~~~~~~~~-~~~~~~~~~Gl~~aii~~~~~~~------ 74 (492)
T PRK10459 2 SLREKTISGAKWTAISTVIIIGLQLVQLTVLARILDNHQFGLLTMSLVII-GFADTLSDMGIGASIIQRQDISH------ 74 (492)
T ss_pred ChHHHHHccccHHHHHHHHHHHHHHHHHHHHHHhCCHHHccHHHHHHHHH-HHHHHHHHcCHHHHHHhcccCCH------
Confidence 57889999999999999999999999999999999999999999876643 34456788899999998644321
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccCCch-hhHHHHHHHHHHHHhhhhhHHHHHHHhHhHHHHHHHHHHH
Q 018169 87 NAAKLLKVAWLTLPLGIFITIGACFFVLWWQGLSYSNPY-AQAIFINGFACVLELLAEPLYILSQNLLLLRLRLVVETVA 165 (360)
Q Consensus 87 ~~~~~~n~awl~i~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~~~E~~a 165 (360)
++.-+..|+++..|+++.++.... ..+....+++|. ...+.+.++...+..+.+.+....||+++++.....|...
T Consensus 75 --~~~~~~~~~~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~r~~~f~~~a~~~~~~ 151 (492)
T PRK10459 75 --LQLSTLYWLNVGLGIVVFVLVFLL-SPLIADFYHNPELAPLIKTLSLAFVIIPIGQQFRALLQKELEFNKLAKIEISA 151 (492)
T ss_pred --HHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHcCChhhHHHHHHHHHHHHHHHHhhHHHHHHHHHhhhHHHHHHHHHH
Confidence 112233455666666555443322 222233345554 4566777888888899999999999999999999999999
Q ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCCCcccCcccccHHHHHHHHHHHHHH
Q 018169 166 TFSRCFTMCILIVKQYEMEKGIVFALSQVAYAASLFLGYWGYFLLFGAFKTSDLFPFRLGNMMSYDKQLANMCTLFTFQS 245 (360)
Q Consensus 166 ~~~~~~~~v~l~~~~~~~~a~~~fa~gql~~s~~~~~~y~~~~~~~~~~~~~~~~P~r~~~~~~~~~~ll~~~~~~~~qs 245 (360)
.+...++++.++.... +.+++++++++.++...+.++.... +..-|+.. .+....|++++++.+.+..+
T Consensus 152 ~i~~~~~~i~~~~~~~---g~~~l~~~~~~~~~~~~l~~~~~~~-------~~~~~~~~-~~~~~~k~ll~~~~~~~~~~ 220 (492)
T PRK10459 152 VVAGFTFAVVSAFFWP---GALAAILGYLVNSSVRTLLFGYFGR-------KIYRPALH-FSLASVKPNLSFGAWQTAER 220 (492)
T ss_pred HHHHHHHHHHHHHHCC---cHHHHHHHHHHHHHHHHHHHHHHhc-------ccCCccce-ecHHHHHHHHhhhHHHHHHH
Confidence 9998888877665533 4566777888776544333322111 01112211 11122389999999999999
Q ss_pred HHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhhhHHHHHHHHHHHHHHH
Q 018169 246 FRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKSKKIGNSLAEALKLVLL 325 (360)
Q Consensus 246 i~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~~~~~~~l~~~L~~~~~ 325 (360)
+..++.++.|++++|.+.++++.|.|+.+.++.+++...+..++....+|.+|+..+ |.++.++.+.+.++....
T Consensus 221 ~~~~~~~~~d~~~lg~~lg~~~vG~Y~~A~~l~~~~~~~i~~~i~~v~~P~~s~~~~-----~~~~~~~~~~~~~~~~~~ 295 (492)
T PRK10459 221 IINYLNTNIDTILIGRILGAEVLGGYNLAYNVATVPPMKINPIITRVAFPVFAKIQD-----DTEKLRVGFLKLLSVLGI 295 (492)
T ss_pred HHHHHHhcCchhhhhHhhchHhhhhHHHHHHHHHHHHHHHHHHHHHHHhHHHHHhcC-----CHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999998888899999999999632 234677788888888888
Q ss_pred HHHHHHHhcccChHHHHHHHhcCCcCccc
Q 018169 326 IGMFFIELKFSLPIYEFNFVVKGICLTIS 354 (360)
Q Consensus 326 lgl~~~~~G~~~s~~ll~~llG~kW~~~~ 354 (360)
+++++.......+++++++++|++|.+..
T Consensus 296 ~~~p~~~~l~~~a~~ii~ll~g~~~~~a~ 324 (492)
T PRK10459 296 INFPLLLGLMVVSNNFVPLVFGEKWNSAI 324 (492)
T ss_pred HHHHHHHHHHHHhHHHHHHhcChhHHhHH
Confidence 88887766666999999999999997644
No 4
>COG2244 RfbX Membrane protein involved in the export of O-antigen and teichoic acid [General function prediction only]
Probab=99.81 E-value=7.3e-18 Score=170.81 Aligned_cols=326 Identities=14% Similarity=0.074 Sum_probs=220.0
Q ss_pred CcchhhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHHHHHhcccCCCCccchh
Q 018169 7 DHSTSLSRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRRACMRADIKCDGASREE 86 (360)
Q Consensus 7 ~~~~~~~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~a~lr~~~~~~~~~~~~ 86 (360)
+..++..|++.|+...++.+++++|+...+++|.++||+||+++....+.... .-+++-|+..++.|.-...++.+++.
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lar~lg~~~~G~~~~~~~~~~~~-~~i~~~G~~~ai~r~ia~~~~~~~~~ 81 (480)
T COG2244 3 SLKKKLIKGALWLLLGTLISALLGLITIPLLARLLGPEGFGLYALALAIIGLF-SILADFGLPAAITREIAEYREKGEYL 81 (480)
T ss_pred hHHHHHHhhchHHHHHHHHHHHHHHHHHHHHHHHhCcccceeeehHHHHHHHH-HHHHHcCCcHHHHHHHHHhhcccHHH
Confidence 34567899999999999999999999999999999999999999987754443 45567799999999655443322222
Q ss_pred hHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhhccccCCchhhHHHHHHHHHHHHhhhhhHHHHHHHhHhHHHHHHHHHHH
Q 018169 87 NAAKL-LKVAWLTLPLGIFITIGACFFVLWWQGLSYSNPYAQAIFINGFACVLELLAEPLYILSQNLLLLRLRLVVETVA 165 (360)
Q Consensus 87 ~~~~~-~n~awl~i~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~~~E~~a 165 (360)
..... .... +...+....+.... ...... ..+.+...+.+.+++..+...........|+..+++..+......
T Consensus 82 ~~~~~~~~~~---l~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (480)
T COG2244 82 LLILLSVLLL---LLLALILLLLLLLI-AYLLAP-IDPVLALLLRILSLALLLLPLSSVLRGLFQGFGRFGPLALSIVSS 156 (480)
T ss_pred HHHHHHHHHH---HHHHHHHHHHHHHH-HHHhcc-cChhhHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcccchhHHHHH
Confidence 21111 1111 11111111111111 111111 112235667778888888888888889999998888877773333
Q ss_pred -HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCCCcc-cCcccccHHHHHHHHHHHH
Q 018169 166 -TFSRCFTMCILIVKQYEMEKGIVFALSQVAYAASLFLGYWGYFLLFGAFKTSDLFPFRL-GNMMSYDKQLANMCTLFTF 243 (360)
Q Consensus 166 -~~~~~~~~v~l~~~~~~~~a~~~fa~gql~~s~~~~~~y~~~~~~~~~~~~~~~~P~r~-~~~~~~~~~ll~~~~~~~~ 243 (360)
.+......+. ......+.++...+.+.........+... . ...++.. +.....-+++++++.++..
T Consensus 157 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-------~~~~~~~~~~~~~~~~~~l~~~~p~~~ 224 (480)
T COG2244 157 IFLLAAVFALL---FAALGLAVWALVLGAVVSLLVLLILLGKK--K-------RGLKRPILRFSLALLKELLRFGLPLLL 224 (480)
T ss_pred HHHHHHHHHHH---HHhhhHHHHHHHHHHHHHHHHHHHHHHHh--h-------hhccccccCchhHHHHHHHHHhhHHHH
Confidence 1222222111 11111344555566665432222222101 0 0011111 0012344899999999999
Q ss_pred HHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhhhHHHHHHHHHHHHH
Q 018169 244 QSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKSKKIGNSLAEALKLV 323 (360)
Q Consensus 244 qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~~~~~~~l~~~L~~~ 323 (360)
.++...+.++.|+++++.+.++++.|.|+ +.+.-..+...+..|+....+|..|+..++++. ++.++.+...++..
T Consensus 225 ~~~~~~l~~~~D~~~i~~~l~~~~vG~Y~-~a~~i~~~~~~~~~~l~~~l~P~~s~~~~~~~~---~~~~~~~~~~~~~~ 300 (480)
T COG2244 225 SSLLNFLFTNIDTLLLGLFLGPAQVGIYS-AAQRLVSLLLIVASALNRVLFPALSRAYAEGDR---KALKKLLRQSLKLL 300 (480)
T ss_pred HHHHHHHHHHHHHHHHHHHhhhhHheecc-cccHHHHHHHHHHHHHHHHHHHHHHHHHHcCcH---HHHHHHHHHHHHHH
Confidence 99999999999999999999999999999 777777778999999999999999999887533 35556777788888
Q ss_pred HHHHHHHHHhcccChHHHHHHHhcCCcCccc
Q 018169 324 LLIGMFFIELKFSLPIYEFNFVVKGICLTIS 354 (360)
Q Consensus 324 ~~lgl~~~~~G~~~s~~ll~~llG~kW~~~~ 354 (360)
..++.+++..-...+++++.+++|++|.+..
T Consensus 301 ~~~~~p~~~~l~~~~~~~i~~~fg~~~~~~~ 331 (480)
T COG2244 301 LLISIPALLGLLLLAPPIITLLFGEKYASAA 331 (480)
T ss_pred HHHHHHHHHHHHHHHhhhheeecCCcccchh
Confidence 8888888877777899999999999998643
No 5
>PRK15099 O-antigen translocase; Provisional
Probab=99.77 E-value=2.1e-16 Score=157.81 Aligned_cols=320 Identities=10% Similarity=0.026 Sum_probs=201.2
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHHHHHhcccCCCCccchhhHHH
Q 018169 11 SLSRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRRACMRADIKCDGASREENAAK 90 (360)
Q Consensus 11 ~~~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~a~lr~~~~~~~~~~~~~~~~ 90 (360)
+..|++.|+...+++..+++|+.+-+++|+++||++|+++....++... ..+..-|+-.+..|.-... .+|+++.++
T Consensus 2 ~~~k~~~~~~~~~~~~~~~~~l~~~i~ar~Lg~~~~G~~~~~~~~i~~~-~~~~~~G~~~a~~~~ia~~--~~~~~~~~~ 78 (416)
T PRK15099 2 SLAKASLWTAASTLVKIGAGLLVVKLLAVSFGPAGVGQAGNFRQLITVL-GVLAGAGIFNGVTKYVAQY--HDQPQQLRA 78 (416)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCcHHHHHHHHHHHHHHHH-HHHHcCCccceeeeeHHhc--CCCHHHHHH
Confidence 4678999999999999999999999999999999999988765544333 3343446644442211111 122234455
Q ss_pred HHHHHH-HHHHHHHHHHHHHHHHHHHhhc-cccC-CchhhHHHHHHHHHHHHhhhhhHHHHHHHhHhHHHHHHHHHHHHH
Q 018169 91 LLKVAW-LTLPLGIFITIGACFFVLWWQG-LSYS-NPYAQAIFINGFACVLELLAEPLYILSQNLLLLRLRLVVETVATF 167 (360)
Q Consensus 91 ~~n~aw-l~i~~g~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~~~E~~a~~ 167 (360)
+.+++. +++..|++++++.... ..+.. .... +++...+...+...+.-.+.+......+.. .+.+.+....+
T Consensus 79 ~~~~~~~l~~~~~~i~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lr~~----~~~~~~~~~~~ 153 (416)
T PRK15099 79 VVGTSSAMVLGFSTLLALVFLLA-AAPISQGLFGHTDYQGVVRAVALIQMGIAWANLLLAILKGF----RDAAGNALSLI 153 (416)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHhCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHH----HHHHHHHHHHH
Confidence 666654 4666666666554332 11211 1122 334444444444444444444443444443 33444444445
Q ss_pred HHHHHHHHH---HHhccCch-hHHHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCCCc---ccCcccccHHHHHHHHH
Q 018169 168 SRCFTMCIL---IVKQYEME-KGIVFALSQVAYAASLFLGYWGYFLLFGAFKTSDLFPFR---LGNMMSYDKQLANMCTL 240 (360)
Q Consensus 168 ~~~~~~v~l---~~~~~~~~-a~~~fa~gql~~s~~~~~~y~~~~~~~~~~~~~~~~P~r---~~~~~~~~~~ll~~~~~ 240 (360)
...++.+.+ .+...+.+ +.++..++|....+. ..|+.+ ++ +. +|.+ .+.+....|++++++.+
T Consensus 154 ~~~~~~i~l~i~~~~~~Gv~Ga~iat~i~~~i~~~~--~~~~~~-~~------~~-~~~~~~~~~~~~~~~k~ll~~g~p 223 (416)
T PRK15099 154 VGSLIGVAAYYLCYRLGGYEGALLGLALVPALVVLP--AGIMLI-RR------GT-IPLSYLKPSWDNGLAGQLGKFTLM 223 (416)
T ss_pred HHHHHHHHHHHHHHHHhcchHHHHHHHHHHHHHHHH--HHHHHH-Hc------cc-eehHhhhccCCHHHHHHHHHHHHH
Confidence 555544432 22222444 335666666554211 122221 11 01 1211 11122234799999999
Q ss_pred HHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhhhHHHHHHHHHH
Q 018169 241 FTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKSKKIGNSLAEAL 320 (360)
Q Consensus 241 ~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~~~~~~~l~~~L 320 (360)
...+++...+.+-.|+.+++...+.++.|.|+++.++.+.+...+..|+.++.+|..++.. + + ++.++.+.+.+
T Consensus 224 ~~~~~~~~~i~~~~~~~~l~~~~g~~~vg~y~~a~~i~~~~~~~~~~~~~~a~~P~~s~~~-~--~---~~~~~~~~~~~ 297 (416)
T PRK15099 224 ALITSVTLPVAYVMMRNLLAAHYSWDEVGIWQGVSSISDAYLQFITASFSVYLLPTLSRLT-E--K---RDITREIVKAL 297 (416)
T ss_pred HHHHHHHHHHHHHHHHHHHHhcCCHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC-C--h---HHHHHHHHHHH
Confidence 9999999999999999999988889999999999999999999999999999999999951 1 1 34555555566
Q ss_pred HHHHHHHHHHHHhcccChHHHHHHHhcCCcCccc
Q 018169 321 KLVLLIGMFFIELKFSLPIYEFNFVVKGICLTIS 354 (360)
Q Consensus 321 ~~~~~lgl~~~~~G~~~s~~ll~~llG~kW~~~~ 354 (360)
+....++++........+|+++++++|++|.+.+
T Consensus 298 ~~~~~~~~~~~~~~~l~a~~ii~l~~g~~~~~~~ 331 (416)
T PRK15099 298 KFVLPAVAAASFTVWLLRDFAIWLLFSNKFTAMR 331 (416)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHHH
Confidence 6666666655554445799999999999998644
No 6
>TIGR02900 spore_V_B stage V sporulation protein B. SpoVB is the stage V sporulation protein B of the bacterial endopore formation program in Bacillus subtilis and various other Firmcutes. It is nearly universal among endospore-formers. Paralogs with rather high sequence similarity to SpoVB exist, including YkvU in B. subtilis and a number of proteins in the genus Clostridium. Member sequences for the seed alignment were chosen to select those proteins, no more than one to a genome, closest to B. subtilis SpoVB in a neighbor joining tree.
Probab=99.77 E-value=2.4e-16 Score=159.67 Aligned_cols=329 Identities=15% Similarity=0.113 Sum_probs=213.3
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHHHHHhcccCCCCccchhhHHHHH
Q 018169 13 SRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRRACMRADIKCDGASREENAAKLL 92 (360)
Q Consensus 13 ~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~a~lr~~~~~~~~~~~~~~~~~~ 92 (360)
.|++.|++..+++.++++|+.+.+++|.++||+||.+++...+.... ..+...|+-.++.|.-....+.+|++..++.+
T Consensus 2 ~~~~~~~~~~~~~~~~~~~i~~~~l~r~Lg~~~~G~~~~~~~~~~~~-~~~~~~Gl~~a~~~~is~~~~~~~~~~~~~~~ 80 (488)
T TIGR02900 2 LKGTFILTIANLITRILGFIFRIVLSRILGAEGVGLYGMAMPIYFLF-ITLTTGGLPVAISKFVAEASAKNDRKNIKKIL 80 (488)
T ss_pred hHhHHHHHHHHHHHHHHHHHHHHHHHHHhCHHHhhHHHHHHHHHHHH-HHHHhCCcHHHHHHHHHHHHhccchhhHHHHH
Confidence 47889999999999999999999999999999999999876654433 33455588888877421111111212233444
Q ss_pred H-HHHHHHHHHHHHHHHHHHHHHHhhcc-ccCCch-hhHHHHHHHHHHHHhhhhhHHHHHHHhHhHHHHHHHHHHHHHHH
Q 018169 93 K-VAWLTLPLGIFITIGACFFVLWWQGL-SYSNPY-AQAIFINGFACVLELLAEPLYILSQNLLLLRLRLVVETVATFSR 169 (360)
Q Consensus 93 n-~awl~i~~g~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~~~E~~a~~~~ 169 (360)
. ..|+++..|+++++++... ..+... ..+++. ...+..++.+.++..+.+......|.+.+++.....+....+.+
T Consensus 81 ~~~~~l~l~~~~~~~~l~~~~-~~~i~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~i~~i~~ 159 (488)
T TIGR02900 81 KVSLIFTLIWSLIVTAIVFLL-SPFIASTLLKDERSLYSLLVICPAMPFIALSSVLKGYFQGISNMKPPAYIQVIEQIVR 159 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHHh-hHHHHHHHcCChhHHHHHHHHHHHHHHHHHHHHHHHHHhhhccchHhHHHHHHHHHHH
Confidence 4 4455666666555443222 111111 123443 23456677888888889998899999999999999999999998
Q ss_pred HHHHHHHHHhc--cCch-hHHHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCCCcccCcccccHHHHHHHHHHHHHHH
Q 018169 170 CFTMCILIVKQ--YEME-KGIVFALSQVAYAASLFLGYWGYFLLFGAFKTSDLFPFRLGNMMSYDKQLANMCTLFTFQSF 246 (360)
Q Consensus 170 ~~~~v~l~~~~--~~~~-a~~~fa~gql~~s~~~~~~y~~~~~~~~~~~~~~~~P~r~~~~~~~~~~ll~~~~~~~~qsi 246 (360)
....+.+.... .+.| .+.+.+++.....+...+..+.++.+....+.+.....+.+.+....|++++++.+.+.+++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~v~g~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~l~~~~~p~~l~~~ 239 (488)
T TIGR02900 160 ISVVALLISAFLPYGLEYAVAGAYLSLVLGELVSLLYLYFFFKRKKSFSIRFPFFDYKSEGKALLFDLFSVSLPLTLSRF 239 (488)
T ss_pred HHHHHHHHHHHHhcChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccccccCcchHHHHHHHHHHHHHHHHHHH
Confidence 87766554322 2222 23333344333322222211111111110000000000000111234799999999999999
Q ss_pred HHHHHhhhceeeeEeccCC---------Ccchhh-hHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhhhHHHHHH
Q 018169 247 RKLLLQEGEKLVLVWLDTP---------YNQAVY-GLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKSKKIGNSL 316 (360)
Q Consensus 247 ~k~lltegDk~vl~~~~~~---------~~qG~Y-~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~~~~~~~l 316 (360)
..++.++.|++++++..+. ++.|.| +++.++..++ -.+...+..+..|.+++..++++. ++.++.+
T Consensus 240 ~~~~~~~~d~~ii~~~l~~~g~~~~~a~~~~g~~~~~a~~i~~~~-~~~~~~l~~~~~p~~s~~~~~~~~---~~~~~~~ 315 (488)
T TIGR02900 240 IGSLLYFLETLLVPQRLVIAGVTYREATSLYGKLSGMAMPLLTFP-AVITSSLSTALVPDISEAMAKKNY---SSIEKRI 315 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHChHHHHHHhH-HHHHHHHHHHHHHHHHHHHHcCCH---HHHHHHH
Confidence 9999999999999876532 234555 4666677777 477888999999999999876533 4566777
Q ss_pred HHHHHHHHHHHHHHHHhcccChHHHHHHHhc
Q 018169 317 AEALKLVLLIGMFFIELKFSLPIYEFNFVVK 347 (360)
Q Consensus 317 ~~~L~~~~~lgl~~~~~G~~~s~~ll~~llG 347 (360)
.+.++....+++++.......+|+++++++|
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~ii~~~~~ 346 (488)
T TIGR02900 316 NQAIKISLLLGLITTVILLVIPDELGALFYG 346 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC
Confidence 7788998888888777777789999999885
No 7
>PF01943 Polysacc_synt: Polysaccharide biosynthesis protein; InterPro: IPR002797 Members of this family are integral membrane proteins [], and many are implicated in the production of polysaccharide. The family includes RfbX part of the O antigen biosynthesis operon [], and SpoVB from Bacillus subtilis (Q00758 from SWISSPROT), which is involved in spore cortex biosynthesis [].; GO: 0000271 polysaccharide biosynthetic process, 0016020 membrane
Probab=99.74 E-value=2e-15 Score=139.86 Aligned_cols=269 Identities=15% Similarity=0.186 Sum_probs=173.4
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHHHHHhcccCCCCccchhhHHHHH
Q 018169 13 SRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRRACMRADIKCDGASREENAAKLL 92 (360)
Q Consensus 13 ~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~a~lr~~~~~~~~~~~~~~~~~~ 92 (360)
.|++.|....++++++++|+.+.+++|.++||+||..+....+. +....+.+-|+..+..|.-..+++. ++..+...
T Consensus 2 ~k~~~~~~~~~~~~~~~~~~~~~il~r~l~~~~~G~~~~~~~~~-~~~~~~~~~G~~~~~~r~~~~~~~~--~~~~~~~~ 78 (273)
T PF01943_consen 2 LKNSLWLFLSNILSALIGFITIPILARYLGPEEYGIYSLALSIV-SLLSILADLGLSQAIVRFIAEYKDK--KELRSAYF 78 (273)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhCHHHhHHHHHHHHHH-HHHHHHHhhhhHHHHHHHHHHhhhh--HHHHHHHH
Confidence 57889999999999999999999999999999999999876644 4455677889999999865443221 11112222
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhccccCCch-hhHHHHHHHHH-HHHhhhhhHHHHHHHhHhHHHHHHHHHHHHHHHH
Q 018169 93 KVAWLTLPLGIFITIGACFFVLWWQGLSYSNPY-AQAIFINGFAC-VLELLAEPLYILSQNLLLLRLRLVVETVATFSRC 170 (360)
Q Consensus 93 n~awl~i~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ls~-iie~l~eP~~~~~qr~l~~~~r~~~E~~a~~~~~ 170 (360)
........++.++...... .. . ...++. .....++.+.. ++...........|.+.+++.....+....+.+.
T Consensus 79 ~~~~~~~~~~~~i~~~~~~--~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (273)
T PF01943_consen 79 SSVLFLLLIFSLIFLLILL--IA--S-FFGNPSLSLILIILALLILILSSLSSVFSGLLQGLQRFKYIAISNIISSLLSL 153 (273)
T ss_pred HHHHHHHHHHHHHHHHHHH--HH--H-HcCCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 2222211111111111111 11 1 222332 22222222222 4566666666677777777777777777777777
Q ss_pred HHHHHHHHhccCchhHHHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCCCcccCcccccHHHHHHHHHHHHHHHHHHH
Q 018169 171 FTMCILIVKQYEMEKGIVFALSQVAYAASLFLGYWGYFLLFGAFKTSDLFPFRLGNMMSYDKQLANMCTLFTFQSFRKLL 250 (360)
Q Consensus 171 ~~~v~l~~~~~~~~a~~~fa~gql~~s~~~~~~y~~~~~~~~~~~~~~~~P~r~~~~~~~~~~ll~~~~~~~~qsi~k~l 250 (360)
+..+.......+ +..+..++....+...+.++.+.... ..|.+...+....|++++++.+++..++...+
T Consensus 154 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
T PF01943_consen 154 LLILLLLFLGSS---LWGFLLGLVISSLVSLIISLFYLRRK-------LRPRFSFFSKKFFKEILRFGLPLFLSSLLSWL 223 (273)
T ss_pred HHHHHHHHHhhh---HHHHHHHHHHHHHHHHHHHHHHHHHH-------HcccccccchHHHHHHHHHHHHHHHHHHHHHH
Confidence 666655444332 44445555555433322222221110 11222212234458999999999999999999
Q ss_pred HhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhh
Q 018169 251 LQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARS 300 (360)
Q Consensus 251 ltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~ 300 (360)
.++.||++++.+.+.++.|.|+++.++++. ...+..++....+|.+||+
T Consensus 224 ~~~~d~~ii~~~~g~~~vg~Y~~a~~l~~~-~~~~~~~~~~~~~P~~s~l 272 (273)
T PF01943_consen 224 YSQIDRLIIGYFLGPEAVGIYSVAYRLASA-ISFLLSSISTVLFPRLSRL 272 (273)
T ss_pred HHHhHHHHHHHhCCHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999997 4555667766999999986
No 8
>TIGR01695 mviN integral membrane protein MviN. This model represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII.
Probab=99.70 E-value=2.3e-14 Score=145.79 Aligned_cols=326 Identities=12% Similarity=0.004 Sum_probs=218.0
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhh-HHHHHHHHHHHHHHHHHhHHHHHHHHHhcccCCCCccchhhHH
Q 018169 11 SLSRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADY-AIYAVQFHLFVTCVLFLSREGFRRACMRADIKCDGASREENAA 89 (360)
Q Consensus 11 ~~~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~f-Gi~av~l~l~~~tvlflsre~~r~a~lr~~~~~~~~~~~~~~~ 89 (360)
++.|++.++.+.++++|+.+|+-..+++|.+.|+++ |.+++...+.......+..-|+..+.++.-..+++.+ ++..+
T Consensus 1 ~~~k~~~i~~~~~~~~~~~~~~~~~~~a~~lG~~~~~~~~~~~~~i~~~~~~~~~~~g~~~a~i~~~~~~~~~~-~~~~~ 79 (502)
T TIGR01695 1 SLLKSTLIVSLGTLFSRITGFVRDAIIASAFGAGLTADAFNVAFVIPNFFRRLFAEGAFNSAFVPVFTKAKKKE-KEARR 79 (502)
T ss_pred ChHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCChHhhHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHhhh-hHHHH
Confidence 467999999999999999999999999999999999 9888877654333333444568888877433221111 11112
Q ss_pred HHHHHHHHHH-HHHHHHHHHHHHHHHHhhcc----ccCCch----hhHHHHHHHHHHHHhhhhhHHHHHHHhHhHHHHHH
Q 018169 90 KLLKVAWLTL-PLGIFITIGACFFVLWWQGL----SYSNPY----AQAIFINGFACVLELLAEPLYILSQNLLLLRLRLV 160 (360)
Q Consensus 90 ~~~n~awl~i-~~g~~~~~~~~~~~~~~~~~----~~~~~~----~~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~~ 160 (360)
...+..+... ..+++++++.... ..+... ..+++. ..-+.+.+.+.++..+........|.+.+++.-..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~i~~~~~~g~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 158 (502)
T TIGR01695 80 AFANTVTTLLILSLLLVVLIGIFF-APFVISLLAPGFADETRSLAVSLTRIMFPYLLLISLAAVFGGILNARKRFFIPSF 158 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHhcCCCCccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCeeHHHHH
Confidence 3445444422 2232223222111 111111 123332 24567788888888888888889999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCCCcccCcccccHHHHHHHHH
Q 018169 161 VETVATFSRCFTMCILIVKQYEMEKGIVFALSQVAYAASLFLGYWGYFLLFGAFKTSDLFPFRLGNMMSYDKQLANMCTL 240 (360)
Q Consensus 161 ~E~~a~~~~~~~~v~l~~~~~~~~a~~~fa~gql~~s~~~~~~y~~~~~~~~~~~~~~~~P~r~~~~~~~~~~ll~~~~~ 240 (360)
.+....+...+. +.+.....+.|+.. .+++.++..+...+.++.+..+.. ...-|+.. .+...-||+++++.+
T Consensus 159 ~~i~~~i~~i~~-~~~~~~~~g~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~k~~l~~~~p 231 (502)
T TIGR01695 159 SPILFNIGVILS-LLFFDWNYGQYSLA-LAIGVLIGGVAQLLIQLPFLRKAG----FLLKPRFN-FRDPGLKRFLKLFLP 231 (502)
T ss_pred HHHHHHHHHHHH-HHHHHcccchHHHH-HHHHHHHHHHHHHHHHHHHHHHCC----CcccCcCC-CCChhHHHHHHHHHH
Confidence 888877655442 22223322323221 124554444333333322222111 11112111 111233899999999
Q ss_pred HHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhhhHHHHHHHHHH
Q 018169 241 FTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKSKKIGNSLAEAL 320 (360)
Q Consensus 241 ~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~~~~~~~l~~~L 320 (360)
...++.+.++.+..|+.+ +...+.++.|.|+.+.++-.++.-.+..++.....|..|+...++++ ++.++.+.+.+
T Consensus 232 ~~~~~~~~~~~~~id~~~-~~~~~~~~v~~~~~a~~l~~~~~~~~~~~i~~~~~P~~s~~~~~~~~---~~~~~~~~~~~ 307 (502)
T TIGR01695 232 TTLGSSASQITLLINTAL-ASFLEIGSVSALYYANRIYQLPLGIFGISLSTVLLPKLSRHASEGNW---NELRDLLNQGI 307 (502)
T ss_pred HHHHHHHHHHHHHHHHHH-HhcCCcchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCH---HHHHHHHHHHH
Confidence 999999999999999977 77788899999999999999888888899999999999999876533 46778888888
Q ss_pred HHHHHHHHHHHHhcccChHHHHHHHhcCC
Q 018169 321 KLVLLIGMFFIELKFSLPIYEFNFVVKGI 349 (360)
Q Consensus 321 ~~~~~lgl~~~~~G~~~s~~ll~~llG~k 349 (360)
+....++++........+++++++++|++
T Consensus 308 ~~~~~~~~~~~~~l~~~~~~ii~l~~~~~ 336 (502)
T TIGR01695 308 RLSLLLTIPSSFGLLILSIPIVSLLFERG 336 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhccC
Confidence 99999988888877789999999999953
No 9
>PF13440 Polysacc_synt_3: Polysaccharide biosynthesis protein
Probab=99.70 E-value=5.9e-15 Score=135.77 Aligned_cols=248 Identities=17% Similarity=0.304 Sum_probs=168.7
Q ss_pred HHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHHHHHhcccCCCCccchhhHHHHHHHHHHHHHHHHHHHH
Q 018169 28 GIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRRACMRADIKCDGASREENAAKLLKVAWLTLPLGIFITI 107 (360)
Q Consensus 28 lltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~a~lr~~~~~~~~~~~~~~~~~~n~awl~i~~g~~~~~ 107 (360)
+++|+.+.+++|.++|||||..+....... .+..+.+.|++..+.|+.+.+++ +..+..+.... .++++++
T Consensus 2 ~~~f~~~~~lar~l~~~~~G~~~~~~s~~~-~~~~~~~~g~~~~~~~~~~~~~~-----~~~~~~~~~~~---~~~~~~~ 72 (251)
T PF13440_consen 2 GINFLFLILLARYLGPEDFGIYALIFSIVS-ILSIVASLGLRQSLVRSAARDKQ-----DIRSLLRFSLL---VSLLLAV 72 (251)
T ss_pred hHHHHHHHHHHHHCCHHHhHHHHHHHHHHH-HHHHHHHHHHHHHHHHhhccCHH-----HHHHHHHHHHH---HHHHHHH
Confidence 468999999999999999999998766444 44456688999999995333211 23334444322 1222222
Q ss_pred HHHHHHHHhhccccCCch-hhHHHHHHHHHHHHhhhhhHHHHHHHhHhHHHHHHHHHHHHHHHHHHHHHHHHhccCchhH
Q 018169 108 GACFFVLWWQGLSYSNPY-AQAIFINGFACVLELLAEPLYILSQNLLLLRLRLVVETVATFSRCFTMCILIVKQYEMEKG 186 (360)
Q Consensus 108 ~~~~~~~~~~~~~~~~~~-~~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~~~E~~a~~~~~~~~v~l~~~~~~~~a~ 186 (360)
+++..... ......++. ...+.+.++..+.+.+.+......+.+.++++-...+....+.+.+..+.+.+...+.++.
T Consensus 73 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (251)
T PF13440_consen 73 ILAILAIL-IAYFFGDPELFWLLLLLALAIFFSALSQLFRSILRARGRFRAYALIDIVRSLLRLLLLVLLLYLGLNLWSI 151 (251)
T ss_pred HHHHHHHH-HHHHhCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHcCcHHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHH
Confidence 22211001 111123333 3456677788888899999989999999999999999999988865555554443443333
Q ss_pred -HHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCCCcccCcccccHHHHHHHHHHHHHHHHHHHHhhhceeeeEeccCC
Q 018169 187 -IVFALSQVAYAASLFLGYWGYFLLFGAFKTSDLFPFRLGNMMSYDKQLANMCTLFTFQSFRKLLLQEGEKLVLVWLDTP 265 (360)
Q Consensus 187 -~~fa~gql~~s~~~~~~y~~~~~~~~~~~~~~~~P~r~~~~~~~~~~ll~~~~~~~~qsi~k~lltegDk~vl~~~~~~ 265 (360)
+++.+++++.. ...+.. . + + . |..+ .+... +++.+.+.++..+++...+.+++|+++++.+.++
T Consensus 152 ~~~~~~~~~~~~---~~~~~~--~---~---~-~-~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 216 (251)
T PF13440_consen 152 LLAFIISALLAL---LISFYL--L---R---R-K-LRLS-FKFSW-RRLLKYGLPFSLSSLLSWLLSQIDRLLIGYFLGP 216 (251)
T ss_pred HHHHHHHHHHHH---HHHHHH--h---c---c-c-cCCC-chhhH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCH
Confidence 45555555542 111111 1 0 0 0 1111 01112 3479999999999999999999999999997799
Q ss_pred CcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhh
Q 018169 266 YNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARS 300 (360)
Q Consensus 266 ~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~ 300 (360)
++.|.|+++..+...+...+.+++.+..+|.+||+
T Consensus 217 ~~~g~y~~a~~l~~~~~~~~~~~i~~~~~p~lar~ 251 (251)
T PF13440_consen 217 EAVGIYSVAQRLASLPASLLSSAISSVFFPKLARM 251 (251)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999999998874
No 10
>TIGR00797 matE putative efflux protein, MATE family. The MATE family consists of probable efflux proteins including a functionally characterized multi drug efflux system from Vibrio parahaemolyticus, a putative ethionine resistance protein of Saccharomyces cerevisiae, and the functionally uncharacterized DNA damage-inducible protein F (DinF) of E. coli. These proteins have 12 probable TMS.
Probab=99.24 E-value=1.6e-08 Score=97.62 Aligned_cols=314 Identities=16% Similarity=0.066 Sum_probs=187.8
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHHHHHhcccCCCCccchhhHHHHHHH-HHHH
Q 018169 20 LATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRRACMRADIKCDGASREENAAKLLKV-AWLT 98 (360)
Q Consensus 20 i~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~a~lr~~~~~~~~~~~~~~~~~~n~-awl~ 98 (360)
+..++...+..++-+.++.+ +.+++.|.+.+...+ ......+. .++..+..+.-......++.+...+..+. .+.+
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~-~g~~~~~~~~~a~~i-~~~~~~~~-~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~ 79 (342)
T TIGR00797 3 ILANILQPLLGLVDTAFVGH-LGPVDLAAVSLGSSV-FMFLFSIL-MGLGTATTALVAQAVGAGNYQRLGRQAQQSLLLA 79 (342)
T ss_pred HHHHHHHHHHHHHHHHHHhc-ccHHHHHHHHHhHHH-HHHHHHHH-HHHHHhHHHHHHHHHCCCChHHHHHHHHHHHHHH
Confidence 34566666777665555555 678888877776443 22222222 26666654422111001111223334433 3445
Q ss_pred HHHHHHHHHHHHHHHHHhh-cccc-CCch----hhHHHHHHHHHHHHhhhhhHHHHHHHhHhHHHHHHHHHHHHHHHHHH
Q 018169 99 LPLGIFITIGACFFVLWWQ-GLSY-SNPY----AQAIFINGFACVLELLAEPLYILSQNLLLLRLRLVVETVATFSRCFT 172 (360)
Q Consensus 99 i~~g~~~~~~~~~~~~~~~-~~~~-~~~~----~~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~~~E~~a~~~~~~~ 172 (360)
...|+++++++... ..+. .... +++. ...+.+++++.....+........|-.-+.+.-...+....++..+.
T Consensus 80 ~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~i~~~~~~i~~ 158 (342)
T TIGR00797 80 LLLGLPVLLVGYFF-IDPLLSLMGADGEVAELAQDYLRILILGIPAYLLNFVLRGFLRGQGDTKTPMYITLIGNVINIIL 158 (342)
T ss_pred HHHHHHHHHHHHHh-HHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCchHHHHHHHHHHHHHHHH
Confidence 55566555443322 1111 1111 2222 13567788888888888888888888888888888888888877777
Q ss_pred HHHHHH-hccCchhHHHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCCCcccCcccccHHHHHHHHHHHHHHHHHHHH
Q 018169 173 MCILIV-KQYEMEKGIVFALSQVAYAASLFLGYWGYFLLFGAFKTSDLFPFRLGNMMSYDKQLANMCTLFTFQSFRKLLL 251 (360)
Q Consensus 173 ~v~l~~-~~~~~~a~~~fa~gql~~s~~~~~~y~~~~~~~~~~~~~~~~P~r~~~~~~~~~~ll~~~~~~~~qsi~k~ll 251 (360)
.+.+.. .... +++.+.+++.++..+...+.+..+.++. .+.+..+..+.+.+....|++++++.+....++...+.
T Consensus 159 ~~~li~~~~g~-~g~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~k~~~~~~~P~~~~~l~~~~~ 235 (342)
T TIGR00797 159 NYILIFGKFGF-LGIVGAALATVISYWLMFLLLLYYIKKA--KKIGLKWEGLLKPDWEVLKRLLKLGLPIAFRVILESLS 235 (342)
T ss_pred hHHHHhcCccc-cccHHHHHHHHHHHHHHHHHHHHHHHhC--CCcccccccccCCCHHHHHHHHHhCchHHHHHHHHHHH
Confidence 666544 2220 2234444455544333222222111110 00000000011111123379999999999999999999
Q ss_pred hhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhhhHHHHHHHHHHHHHHHHHHHHH
Q 018169 252 QEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKSKKIGNSLAEALKLVLLIGMFFI 331 (360)
Q Consensus 252 tegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~~~~~~~l~~~L~~~~~lgl~~~ 331 (360)
++.|+.+++. .+.++.|.|+++.++.+++ -.+...+..+..+..++...+++. ++.++.+...++....+++++.
T Consensus 236 ~~~~~~i~~~-~g~~~v~~~~~a~~~~~~~-~~~~~~~~~a~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 310 (342)
T TIGR00797 236 FALLALLVAR-LGSIALAAHQIALNVESLL-FMPAFGFGIAVSILVGQALGAGDP---KRAKEVARVALKLSLLLGLVLA 310 (342)
T ss_pred HHHHHHHHHH-cCcHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhCCCCH---HHHHHHHHHHHHHHHHHHHHHH
Confidence 9999987766 5688899999999998764 466667888888888888755433 4667777778888888888777
Q ss_pred HhcccChHHHHHHH
Q 018169 332 ELKFSLPIYEFNFV 345 (360)
Q Consensus 332 ~~G~~~s~~ll~~l 345 (360)
..-...+++++++.
T Consensus 311 ~~l~~~~~~i~~~~ 324 (342)
T TIGR00797 311 IILILFREFIARLF 324 (342)
T ss_pred HHHHHHHHHHHHHh
Confidence 66666788877763
No 11
>PF03023 MVIN: MviN-like protein; InterPro: IPR004268 This entry represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII []. Disruption of the MviN open reading frame results in flagellar structures that contain only the basal body and hook complex that lack the flagellum; suggesting that MviN might be involved in flagellin export or assembly []. Genome comparison studies led to MviN being predicted to be a peptidoglycan lipid II flippase though currently there is no direct evidence to support this annotation [].
Probab=98.66 E-value=5.6e-05 Score=76.83 Aligned_cols=216 Identities=13% Similarity=0.083 Sum_probs=151.2
Q ss_pred HHHHHHHHHHHHhhhhhHHHHHHHhHhHHHHHHHHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHHHHHHHHHHH
Q 018169 128 AIFINGFACVLELLAEPLYILSQNLLLLRLRLVVETVATFSRCFTMCILIVKQYEMEKGIVFALSQVAYAASLFLGYWGY 207 (360)
Q Consensus 128 ~~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~~~E~~a~~~~~~~~v~l~~~~~~~~a~~~fa~gql~~s~~~~~~y~~~ 207 (360)
...+.....+.-+++.-.....|.+-+|..-........+.-.+..+. .....+.+.+.+.++|.++.++...+.....
T Consensus 100 l~~i~~~~~~~~~l~~i~~a~L~~~~~F~~~~~~~l~~N~~~I~~~~~-~~~~~~~~~i~~la~g~~~g~~~~~l~~l~~ 178 (451)
T PF03023_consen 100 LLRILAPSILFIGLSSIFSAILNAHRRFLIPALSPLLFNLSIILSLLL-LSNSWGQENIYALAWGVLIGAIIQFLIQLPY 178 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHcCcchHHHHHHHHHHHHHHHHHHH-HHHhcCchHHHHHHHHHHHHHHHHHHHHHHH
Confidence 457777888888888888888888888887777666666543333222 2222221235556666666654433222111
Q ss_pred HHhhcccccCccCCCcccCc--ccccHHHHHHHHHHHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHH
Q 018169 208 FLLFGAFKTSDLFPFRLGNM--MSYDKQLANMCTLFTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMV 285 (360)
Q Consensus 208 ~~~~~~~~~~~~~P~r~~~~--~~~~~~ll~~~~~~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~l 285 (360)
.+.. .+..+++.+ ..--|++++...+....+...|+..--||.+.+.+. ......++-|..+-.+|...+
T Consensus 179 ~~~~-------~~~~~~~~~~~~~~~~~~~~~~~p~~l~~~~~qi~~lv~~~laS~l~-~G~vs~l~YA~~l~~lp~~i~ 250 (451)
T PF03023_consen 179 LRRF-------GFRFRPKFDWRDPNLKRFLKLAIPLLLSSSISQINILVDRALASFLG-EGSVSALNYAQRLYQLPLGIF 250 (451)
T ss_pred HHHC-------CCcccccCCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCC-ccHHHHHHHHHHHHHHHHHHH
Confidence 1111 112222111 111268888889999999999999999999888744 556778888999999999999
Q ss_pred HhhhhhchHHHHHhhhcCCCchhhhHHHHHHHHHHHHHHHHHHHHHHhcccChHHHHHHHhc-CCcCccch
Q 018169 286 FLPFEESSYATFARSASGQYPQKSKKIGNSLAEALKLVLLIGMFFIELKFSLPIYEFNFVVK-GICLTISV 355 (360)
Q Consensus 286 f~Piee~~~~~Fs~~~~~~~~~~~~~~~~~l~~~L~~~~~lgl~~~~~G~~~s~~ll~~llG-~kW~~~~~ 355 (360)
..|+....+|.+||..++++ .++.++.+.+.++...++.+++..+...+++++++++|+ ++-..+++
T Consensus 251 ~~~i~tv~~P~ls~~~~~~d---~~~~~~~~~~~l~~~~~i~iP~~~~~~~~a~~iV~llf~rG~F~~~~~ 318 (451)
T PF03023_consen 251 AVSISTVVFPKLSRLAAEGD---WEEFRKTLRKALRLILLILIPASIGLIVLAEPIVRLLFERGAFTAEDT 318 (451)
T ss_pred HHHHHHHHHHHHHHHHhcCC---HHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHccCCCCHHHH
Confidence 99999999999999987753 346778888899999999999999888999999999994 55554443
No 12
>PRK09575 vmrA multidrug efflux pump VmrA; Reviewed
Probab=98.47 E-value=0.00032 Score=71.20 Aligned_cols=317 Identities=15% Similarity=0.064 Sum_probs=177.0
Q ss_pred CcchhhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHH---HHHhcccCCCCcc
Q 018169 7 DHSTSLSRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRR---ACMRADIKCDGAS 83 (360)
Q Consensus 7 ~~~~~~~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~---a~lr~~~~~~~~~ 83 (360)
++-+++.+-+.=.++.++...+.+++-+.++.|++++++.+.+++...+......+. .++.. +...+..+. +
T Consensus 9 ~~~k~i~~l~~P~~~~~l~~~l~~~~d~~~lg~~~g~~~laa~~~~~~~~~~~~~~~--~~~~~g~~~lvsq~~Ga---~ 83 (453)
T PRK09575 9 SIYRTFWRYTIPSIAAMLVNGLYQIVDGIFIGHYVGAEGLAGINMAWPVIGIILGIG--LMVGMGTGSLLSIKRGE---G 83 (453)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHH--HHHhccHHHHHHHHhcC---C
Confidence 455666677777888899999999999999999999888776665544332222111 12211 233333332 1
Q ss_pred chhhHHHHHHHH-HHHHHHHHHHHHHHHHHHHHhh-ccccCCc--h---hhHHHHHHHHHHHHhhhhhHHHHHHHhHhHH
Q 018169 84 REENAAKLLKVA-WLTLPLGIFITIGACFFVLWWQ-GLSYSNP--Y---AQAIFINGFACVLELLAEPLYILSQNLLLLR 156 (360)
Q Consensus 84 ~~~~~~~~~n~a-wl~i~~g~~~~~~~~~~~~~~~-~~~~~~~--~---~~~~~~~~ls~iie~l~eP~~~~~qr~l~~~ 156 (360)
|++...+..+.+ |.++..+++.+++.... ..+. .....|+ + ..-+.+++++.....+........|..-+-+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~il~l~~~~~~~~~~~~~yl~i~~~~~~~~~l~~~~~~~l~~~g~~~ 162 (453)
T PRK09575 84 DLEKAKRILTTGLLLLLLLGPIVSVILFLF-ADDFLRAQGAEGRTLELALQYIQVLIWGCLFTLGAIALPFLLRNDESPN 162 (453)
T ss_pred CHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHcCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChH
Confidence 222333444443 33555555444433221 1111 1121222 1 1345677777777777777666666655556
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhccCchhH----HHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCCCccc-C--ccc
Q 018169 157 LRLVVETVATFSRCFTMCILIVKQYEMEKG----IVFALSQVAYAASLFLGYWGYFLLFGAFKTSDLFPFRLG-N--MMS 229 (360)
Q Consensus 157 ~r~~~E~~a~~~~~~~~v~l~~~~~~~~a~----~~fa~gql~~s~~~~~~y~~~~~~~~~~~~~~~~P~r~~-~--~~~ 229 (360)
.-......+.+++.+....++... + +++ ++..+++....+.. ..|+ .. ++ . ..+.+.+ . +..
T Consensus 163 ~~~~~~~~~~~~ni~l~~~li~~~-~-~Gi~Gaa~At~is~~~~~~~~-~~~~---~~-~~--~--~~~~~~~~~~~~~~ 231 (453)
T PRK09575 163 LATGLMVIGALINIVLDYLFIGWL-D-WGLTGAAIATALAQLVVTVLG-LGYF---FS-SR--A--NIRLTLKELRFNWS 231 (453)
T ss_pred HHHHHHHHHHHHHHHhhHHHHHhC-C-chhHHHHHHHHHHHHHHHHHH-HHHH---HC-CC--c--eeEEeeccCCcCHH
Confidence 566666666666666666554332 1 333 44445555432211 1121 11 11 1 1111100 0 111
Q ss_pred ccHHHHHHHHHHHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhh
Q 018169 230 YDKQLANMCTLFTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKS 309 (360)
Q Consensus 230 ~~~~ll~~~~~~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~ 309 (360)
.-|++++.+.+.+.+.....+..---..+++.+.+.++.+.|++++|+-++ .-....-+..+.-+.=++....++.
T Consensus 232 ~~~~il~ig~P~~~~~~~~~~~~~~~~~~~~~~g~~~~lAa~~i~~~i~~~-~~~~~~gi~~a~~~lvg~~~Ga~~~--- 307 (453)
T PRK09575 232 LAPKIVLLGSSSFFMYLYGSFVVALHNRLFMEYGSALTVGAYAIVGYLMVL-YYLVAEGIAEGMQPPVSYYFGARQY--- 307 (453)
T ss_pred HHHHHHHhChhHHHHHHHHHHHHHHHHHHHHHhCchHHHHHHHHHHHHHHH-HHHHHHHHHHhhHHHHHHHhcCCCh---
Confidence 236778888877777655444433333344555555678999998887766 4444555677777788888776544
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHhcccChHHHHHH
Q 018169 310 KKIGNSLAEALKLVLLIGMFFIELKFSLPIYEFNF 344 (360)
Q Consensus 310 ~~~~~~l~~~L~~~~~lgl~~~~~G~~~s~~ll~~ 344 (360)
++.++.+..-++.....+++...+....+++++++
T Consensus 308 ~~~~~~~~~~l~l~~~~~~~~~~~~~~~~~~i~~l 342 (453)
T PRK09575 308 DNIKKLLKLAMKVTVLAGIAWVLLLNLFPETMIAL 342 (453)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHh
Confidence 46777777788888888777776666667777766
No 13
>PRK01766 multidrug efflux protein; Reviewed
Probab=98.46 E-value=0.00026 Score=71.54 Aligned_cols=321 Identities=15% Similarity=0.048 Sum_probs=170.3
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHHHHH---hcccCCCCccchhhH
Q 018169 12 LSRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRRACM---RADIKCDGASREENA 88 (360)
Q Consensus 12 ~~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~a~l---r~~~~~~~~~~~~~~ 88 (360)
+.+-+.-.+..++...+..++-+.++.| +.+++.+-+++...+......+. .++-.+.. .+..++ +|.++.
T Consensus 14 il~~~~P~~~~~~~~~~~~~~d~~~i~~-~g~~~laa~~~~~~~~~~~~~~~--~g~~~a~~~~vs~~~g~---~~~~~~ 87 (456)
T PRK01766 14 LLALALPILLAQVAQTAMGFVDTVMAGG-VSATDLAAVAIGTSIWLPVILFG--HGLLLALTPIVAQLNGA---GRRERI 87 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHc-cCHHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHhcC---CChHHH
Confidence 4455556677777777778777766666 57776665555433322111222 24433322 222222 112233
Q ss_pred HHHHHHHH-HHHHHHHHHHHHHHHHHHHhh-ccccCCch----h-hHHHHHHHHHHHHhhhhhHHHHHHHhHhHHHHHHH
Q 018169 89 AKLLKVAW-LTLPLGIFITIGACFFVLWWQ-GLSYSNPY----A-QAIFINGFACVLELLAEPLYILSQNLLLLRLRLVV 161 (360)
Q Consensus 89 ~~~~n~aw-l~i~~g~~~~~~~~~~~~~~~-~~~~~~~~----~-~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~~~ 161 (360)
++..+.+. +++..|++++++.... ..+. .....+|. . .-+.+++.+.+...+........|-.-+.+.-...
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~i~~l~~~~~~~~~~~~~yl~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~ 166 (456)
T PRK01766 88 AHQVRQGLWLALFLSVLIMLVLYNA-VPPILNMMNLEPEVADIAVGYLHALLWGIPAYLLYQVLRSFIDGLGKTKPTMVI 166 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHh-HHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChHHHHH
Confidence 44444443 3445555444332221 1111 12222332 1 23455666666667766666666666666777777
Q ss_pred HHHHHHHHHHHHHHHHHhc-c-CchhHHHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCCCcccCcccccHHHHHHHH
Q 018169 162 ETVATFSRCFTMCILIVKQ-Y-EMEKGIVFALSQVAYAASLFLGYWGYFLLFGAFKTSDLFPFRLGNMMSYDKQLANMCT 239 (360)
Q Consensus 162 E~~a~~~~~~~~v~l~~~~-~-~~~a~~~fa~gql~~s~~~~~~y~~~~~~~~~~~~~~~~P~r~~~~~~~~~~ll~~~~ 239 (360)
...+.+++.+....+++.. + ...++.+.+++.....+...+.++.+..+....+.....+...+.+....|++++++.
T Consensus 167 ~~i~~ivni~l~~~li~~~~~~~~~Gv~Gaa~at~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~il~l~~ 246 (456)
T PRK01766 167 GFLGLLINIPLNYIFIYGKFGFPELGGVGCGVATAIVYWVMFLAMLIYIKRARRFRDFRLFKGLYKPDWAVIKRLLKLGL 246 (456)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCcccccccHHHHHHHHHHHHHHHHHHHHHhChhhhHHHhhccccCCCHHHHHHHHHccc
Confidence 7777777776665554321 0 1123333333433332222222222211111000000001000001122378999999
Q ss_pred HHHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhhhHHHHHHHHH
Q 018169 240 LFTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKSKKIGNSLAEA 319 (360)
Q Consensus 240 ~~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~~~~~~~l~~~ 319 (360)
+...+.....+....|..+++.+ +.++...|++++|+.++.. .+..-+-.+.-+.-++....+++ ++.++.....
T Consensus 247 P~~~~~~~~~~~~~~~~~~~~~~-G~~~lAa~~i~~~i~~~~~-~~~~gl~~a~~~~v~~~~Ga~~~---~~~~~~~~~~ 321 (456)
T PRK01766 247 PIGLAIFFEVSLFAVVTLLVSPL-GTVTVAAHQIALNFSSLLF-MLPLSLAMALTIRVGFELGAGRT---LDARQYAYIG 321 (456)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHc-ChHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHhcCCCH---HHHHHHHHHH
Confidence 99999999888888888888776 4577999999999877642 33333445555556666655433 4677777777
Q ss_pred HHHHHHHHHHHHHhcccChHHHHHH
Q 018169 320 LKLVLLIGMFFIELKFSLPIYEFNF 344 (360)
Q Consensus 320 L~~~~~lgl~~~~~G~~~s~~ll~~ 344 (360)
++....++++........++++.++
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~i~~l 346 (456)
T PRK01766 322 LAVGLGMALLTAIFLVLFREQIALL 346 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 8888777777666666677777765
No 14
>PRK00187 multidrug efflux protein NorA; Provisional
Probab=98.42 E-value=0.00052 Score=69.92 Aligned_cols=318 Identities=15% Similarity=0.030 Sum_probs=173.0
Q ss_pred hhhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHHHH---HhcccCCCCccchh
Q 018169 10 TSLSRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRRAC---MRADIKCDGASREE 86 (360)
Q Consensus 10 ~~~~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~a~---lr~~~~~~~~~~~~ 86 (360)
+++.+-+.=.++.++..-+..++-|.++.| ++++...-+++...+...+..+. .|+..++ +.+..+. +|.+
T Consensus 10 k~il~~a~P~~~~~~~~~~~~~~d~~~v~~-lg~~alAa~~i~~~i~~~~~~~~--~gl~~~~~~i~aq~~Ga---~~~~ 83 (464)
T PRK00187 10 KAILRLAGPLIASQLAHMLMVFTDTLMMGR-LGPEALAGGGLGAASYSFVSIFC--VGVIAAVGTLVAIRHGA---GDIE 83 (464)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHhcC---CChh
Confidence 345566666778888888889999999999 57777665555544332222221 3444333 2222222 1222
Q ss_pred hHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhh-ccccCCch--h---hHHHHHHHHHHHHhhhhhHHHHHHHhHhHHHHH
Q 018169 87 NAAKLLKVAWL-TLPLGIFITIGACFFVLWWQ-GLSYSNPY--A---QAIFINGFACVLELLAEPLYILSQNLLLLRLRL 159 (360)
Q Consensus 87 ~~~~~~n~awl-~i~~g~~~~~~~~~~~~~~~-~~~~~~~~--~---~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~ 159 (360)
..++..+.++. .+.++++..++. .. ..+. .....||. . .-+.+++++...-++....-...|-.-+.+.-.
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~il~l~~~~~ev~~~~~~Yl~i~~~~~~~~~l~~~~~~~l~~~g~~~~~~ 161 (464)
T PRK00187 84 GATRLAQAGLWLAWLLALVAALLL-WN-LKPLLLLFGQAPQNVDAAMQFLHLLPFALPGYLSFMALRGFTSALGRAGPVM 161 (464)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHH-HH-HHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCcHHHH
Confidence 33445555543 444444433321 11 1111 12222332 1 123444444444444444433444444555555
Q ss_pred HHHHHHHHHHHHHHHHHHHhccC--chhH----HHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCCCc---ccCcccc
Q 018169 160 VVETVATFSRCFTMCILIVKQYE--MEKG----IVFALSQVAYAASLFLGYWGYFLLFGAFKTSDLFPFR---LGNMMSY 230 (360)
Q Consensus 160 ~~E~~a~~~~~~~~v~l~~~~~~--~~a~----~~fa~gql~~s~~~~~~y~~~~~~~~~~~~~~~~P~r---~~~~~~~ 230 (360)
.+-..+.+++.+...++++-..+ .+++ ++..+++.... +.+..+.... +.. + .++.+ .+.+...
T Consensus 162 ~~~~~~~~~ni~~~~~lIfg~~g~p~~Gv~Gaalat~i~~~~~~----~~~~~~~~~~-~~~-~-~~~~~~~~~~~~~~~ 234 (464)
T PRK00187 162 VISLAGAVANLLLNYALIEGWFGLPKLGLMGIGLVTALVSNGMA----LALALYIRRH-PAY-A-AYPLRKGLSRPSRAA 234 (464)
T ss_pred HHHHHHHHHHHHHHHHHHcCCCCCccccccchHHHHHHHHHHHH----HHHHHHHHhc-chh-h-hhhhhccccCCCHHH
Confidence 55566666666666555432111 1233 44444443322 1121122211 100 0 01110 0011122
Q ss_pred cHHHHHHHHHHHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhhh
Q 018169 231 DKQLANMCTLFTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKSK 310 (360)
Q Consensus 231 ~~~ll~~~~~~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~~ 310 (360)
-|++++++.+...+++........|..+++++.+ ++...|++++|+.++ .-.+..=+-.+.-+.=++....+++ +
T Consensus 235 ~k~il~lg~P~~~~~~~~~~~~~i~~~~i~~~G~-~alAa~~i~~~i~~l-~~~~~~gi~~a~~~lvgq~~Ga~~~---~ 309 (464)
T PRK00187 235 LRELWRLGLPIGGTYAVEVGLFTFAALCMGALGS-TQLAAHQIALQIVSV-AFMVPVGLSYAVTMRVGQHYGAGRL---L 309 (464)
T ss_pred HHHHHHhhhhHHHHHHHHHHHHHHHHHHHHHcCH-HHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHcCCCH---H
Confidence 3799999999999999999999999999988655 799999999998886 3333334566666777777766543 4
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhcccChHHHHHHHhc
Q 018169 311 KIGNSLAEALKLVLLIGMFFIELKFSLPIYEFNFVVK 347 (360)
Q Consensus 311 ~~~~~l~~~L~~~~~lgl~~~~~G~~~s~~ll~~llG 347 (360)
+.++.....++....++++...+....+++++++.-+
T Consensus 310 ~~~~~~~~~l~~~~~~~~~~~~~~~~f~~~i~~~ft~ 346 (464)
T PRK00187 310 EARRAGRVGIGFGAVVMLLFAGLFWLLPEAIIGLFLD 346 (464)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Confidence 6666666677777777776666666678888877543
No 15
>COG0534 NorM Na+-driven multidrug efflux pump [Defense mechanisms]
Probab=98.00 E-value=0.0094 Score=60.76 Aligned_cols=320 Identities=16% Similarity=0.113 Sum_probs=186.1
Q ss_pred cchhhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHHHHH---hcccCCCCccc
Q 018169 8 HSTSLSRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRRACM---RADIKCDGASR 84 (360)
Q Consensus 8 ~~~~~~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~a~l---r~~~~~~~~~~ 84 (360)
..+.+.+=+.=.+..++..-+.+++-|.++.|+. +++.+-+++...+......++ .+++.++- .+.-+. +|
T Consensus 15 ~~k~l~~la~P~i~~~l~~~l~~~vD~~~vG~~~-~~alaav~la~~i~~~~~~~~--~gl~~g~~~liaq~~Ga---~~ 88 (455)
T COG0534 15 ILKLLLKLAIPIILGNLLQTLYGLVDTFMVGHLG-AEALAAVGLANPIFFLIIAIF--IGLGTGTTVLVAQAIGA---GD 88 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccc-HHHHHHHHHHHHHHHHHHHHH--HHHHHhHHHHHHHHHcC---Cc
Confidence 3444555555567889999999999999999998 888887887766544444333 23333221 222222 22
Q ss_pred hhhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHhh-ccccCCc----hh-hHHHHHHHHHHHHhhhhhHHHHHHHhHhHHH
Q 018169 85 EENAAKLLKV-AWLTLPLGIFITIGACFFVLWWQ-GLSYSNP----YA-QAIFINGFACVLELLAEPLYILSQNLLLLRL 157 (360)
Q Consensus 85 ~~~~~~~~n~-awl~i~~g~~~~~~~~~~~~~~~-~~~~~~~----~~-~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~ 157 (360)
.++.++..+. .|+++.+|+++.++.... .-+. .....++ +. .=+.+..++...-.+........+-.-+.+.
T Consensus 89 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~ll~~l~~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~ 167 (455)
T COG0534 89 RKKAKRVLGQGLLLALLLGLLLAILLLFF-AEPLLRLLGAPAEVLELAAEYLRIILLGAPFALLSFVLSGILRGLGDTKT 167 (455)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHcCCCHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCch
Confidence 2234444444 444666665555443221 1111 1111111 11 2346667777878888888777777778888
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhccCchhH----HHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCCCcc-cCcccccH
Q 018169 158 RLVVETVATFSRCFTMCILIVKQYEMEKG----IVFALSQVAYAASLFLGYWGYFLLFGAFKTSDLFPFRL-GNMMSYDK 232 (360)
Q Consensus 158 r~~~E~~a~~~~~~~~v~l~~~~~~~~a~----~~fa~gql~~s~~~~~~y~~~~~~~~~~~~~~~~P~r~-~~~~~~~~ 232 (360)
-..+-..+.+...+....+++..-+.+++ ++-+++|.+..+.. +.+....++ .......+. +.+....|
T Consensus 168 ~m~~~~~~~~lNivln~llI~g~~g~lGv~GAA~AT~ia~~~~~~~~----~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 241 (455)
T COG0534 168 PMYILLLGNLLNIVLNYLLIFGLFGGLGVAGAALATVIARWIGALLL----LIYLLRKKR--LLSLFKKKLLKPDRKLLK 241 (455)
T ss_pred hHHHHHHHHHHHHHhhHHHHHhccccccchhHHHHHHHHHHHHHHHH----HHHHHhcch--hhhhhhhhccCCCHHHHH
Confidence 88888999999999888877653111334 45555555543222 222111110 000110110 11123347
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhh---hhhchHHHHHhhhcCCCchhh
Q 018169 233 QLANMCTLFTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLP---FEESSYATFARSASGQYPQKS 309 (360)
Q Consensus 233 ~ll~~~~~~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~P---iee~~~~~Fs~~~~~~~~~~~ 309 (360)
|+++.+.+...+++.-.....-=..+++++. .+....|+++.++.++ .+.| +..+.-+.-.+....++.
T Consensus 242 ~i~~lG~p~~~~~~~~~~~~~~~~~~~~~~G-~~~lAa~~i~~~i~~~----~~~~~~gi~~a~~~lvG~~~Ga~~~--- 313 (455)
T COG0534 242 EILRLGLPIFLESLSESLGFLLLTLFVARLG-TVALAAYGIALRIASF----IFMPPFGIAQAVTILVGQNLGAGNY--- 313 (455)
T ss_pred HHHHhcccHHHHHHHHHHHHHHHHHHHHhcC-hHHHHHHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHhCCCCH---
Confidence 8999999988888777666665555666555 6667777777776555 4444 566667777777766544
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHhcccChHHHHHHHhcC
Q 018169 310 KKIGNSLAEALKLVLLIGMFFIELKFSLPIYEFNFVVKG 348 (360)
Q Consensus 310 ~~~~~~l~~~L~~~~~lgl~~~~~G~~~s~~ll~~llG~ 348 (360)
+++++.....++....++++....-...+++++++...+
T Consensus 314 ~~a~~~~~~~~~~~~~~~~~~~~i~~~f~~~i~~lF~~~ 352 (455)
T COG0534 314 KRARRAARLALKLSLLIALLIALLLLLFREPIISLFTTD 352 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 356666666677777766666555555577777764433
No 16
>PRK10367 DNA-damage-inducible SOS response protein; Provisional
Probab=97.93 E-value=0.023 Score=57.63 Aligned_cols=317 Identities=10% Similarity=-0.025 Sum_probs=159.5
Q ss_pred hhhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHH---HHHHhcccCCCCccchh
Q 018169 10 TSLSRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFR---RACMRADIKCDGASREE 86 (360)
Q Consensus 10 ~~~~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r---~a~lr~~~~~~~~~~~~ 86 (360)
+++.+-+.=.+..|+..-+.+++-+.++.|+.++++..-+++...+......+. .++. .+++.+..++++ .+
T Consensus 9 k~il~la~P~~~~~~~~~~~~~vd~~~vg~l~g~~alAa~~l~~~i~~~~~~~~--~~~~~g~~~lvsq~~Ga~~---~~ 83 (441)
T PRK10367 9 KALWRLALPMIFSNITVPLLGLVDTAVIGHLDSPVYLGGVAVGATATSFLFMLL--LFLRMSTTGLTAQAFGAKN---PQ 83 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHhCCCC---HH
Confidence 445565666778888999999999999999777766554554432211111111 1222 234444444322 22
Q ss_pred hHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhh-ccccCCch--h---hHHHHHHHHHHHHhhhhhHHHHHHHhHhHHHHH
Q 018169 87 NAAKLL-KVAWLTLPLGIFITIGACFFVLWWQ-GLSYSNPY--A---QAIFINGFACVLELLAEPLYILSQNLLLLRLRL 159 (360)
Q Consensus 87 ~~~~~~-n~awl~i~~g~~~~~~~~~~~~~~~-~~~~~~~~--~---~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~ 159 (360)
...+.. +..|+++..++++++..... ..+. .....||. . .-+.+.+++...-.+........|-.-+-+.-.
T Consensus 84 ~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~ll~~~g~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~~ 162 (441)
T PRK10367 84 ALARALVQPLLLALGAGALIALLRTPL-IDLALHIVGGSEAVLEQARRFLEIRWLSAPASLANLVLLGWLLGVQYARAPV 162 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccchHHH
Confidence 223333 33333444444443221111 1111 11112222 1 223445555555555555555555555666666
Q ss_pred HHHHHHHHHHHHHHHHHHHhccCchhH----HHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCCCcccCcccccHHHH
Q 018169 160 VVETVATFSRCFTMCILIVKQYEMEKG----IVFALSQVAYAASLFLGYWGYFLLFGAFKTSDLFPFRLGNMMSYDKQLA 235 (360)
Q Consensus 160 ~~E~~a~~~~~~~~v~l~~~~~~~~a~----~~fa~gql~~s~~~~~~y~~~~~~~~~~~~~~~~P~r~~~~~~~~~~ll 235 (360)
.+...+.++..+....+++... +++ ++..++|.+..+.. .|+.+ +.. ..+....-+.++. ....-|+++
T Consensus 163 ~~~ii~~~vni~l~~~lI~~~~--lGv~Gaa~At~is~~~~~i~~--~~~~~-~~~-~~~~~~~~~~~~~-~~~~~~~il 235 (441)
T PRK10367 163 ILLVVGNILNIVLDLWLVMGLH--MNVQGAALATVIAEYATLLIG--LLMVR-KVL-KLRGISLEMLKTA-WRGNFRRLL 235 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHcC--CccHHHHHHHHHHHHHHHHHH--HHHHH-HHH-hhccccHHHhhhh-hHHHHHHHH
Confidence 6666666666666665544321 333 45556666543222 12221 110 0000000001110 001226778
Q ss_pred HHHHHHHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhhhHHHHH
Q 018169 236 NMCTLFTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKSKKIGNS 315 (360)
Q Consensus 236 ~~~~~~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~~~~~~~ 315 (360)
+.+.+...+.....+....=..+++.+. .+....|.++.|+.++.. ....-+..+.-+.=++....++. ++.++.
T Consensus 236 ~ig~P~~~~~~~~~~~~~~~~~~~~~~G-~~alAa~~I~~~i~~~~~-~~~~gl~~a~~~lvg~~~Ga~~~---~~a~~~ 310 (441)
T PRK10367 236 ALNRDIMLRSLLLQLCFGAITVLGARLG-SDIIAVNAVLMTLLTFTA-YALDGFAYAVEAHSGQAYGARDG---SQLLDV 310 (441)
T ss_pred HhCchHHHHHHHHHHHHHHHHHHHHhcC-HHHHHHHHHHHHHHHHHH-HHHHhHHHHHHHHHHHHHcCCCH---HHHHHH
Confidence 8888777777766665555455566554 568889999988777642 22223566666777777766544 355565
Q ss_pred HHHHHHHHHHHHHHHHHhcccChHHHHHH
Q 018169 316 LAEALKLVLLIGMFFIELKFSLPIYEFNF 344 (360)
Q Consensus 316 l~~~L~~~~~lgl~~~~~G~~~s~~ll~~ 344 (360)
....++....++++...+-...+++++.+
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~l 339 (441)
T PRK10367 311 WRAACRQSGIVALLFSLVYALAGEHIIAL 339 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 55566666665554444333345555555
No 17
>PRK10189 MATE family multidrug exporter; Provisional
Probab=97.44 E-value=0.18 Score=51.61 Aligned_cols=312 Identities=8% Similarity=-0.063 Sum_probs=145.2
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHHH---HHhcccCCCCccchhhHH
Q 018169 13 SRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRRA---CMRADIKCDGASREENAA 89 (360)
Q Consensus 13 ~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~a---~lr~~~~~~~~~~~~~~~ 89 (360)
.+-+.=.++.++...+.+++.|.++.| ++++...-+++...+......+. .++..+ ++.+..+.+ |.+...
T Consensus 32 l~la~P~~~~~~~~~~~~~vd~~~vg~-lG~~alAA~~i~~~i~~~~~~~~--~gl~~g~~~lvsq~~Ga~---~~~~~~ 105 (478)
T PRK10189 32 TPLAVPIFIENLCVLLMGVLSTFLVSW-LGKEAMAGVGLADSFNMVIMAFF--AAIDLGTTVVVAFSLGKR---DRRRAR 105 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHh-cCHHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHhcCC---CHHHHH
Confidence 333334556677777777777777776 68887765665544322221111 233322 233333321 112233
Q ss_pred HHHHHH-HHHHHHHHHHHHHHHHHHHHhh-cccc--CCchh-----hHHHHHHHHHHHHhhhhhHHHHHHHhHhHHHHHH
Q 018169 90 KLLKVA-WLTLPLGIFITIGACFFVLWWQ-GLSY--SNPYA-----QAIFINGFACVLELLAEPLYILSQNLLLLRLRLV 160 (360)
Q Consensus 90 ~~~n~a-wl~i~~g~~~~~~~~~~~~~~~-~~~~--~~~~~-----~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~~ 160 (360)
+..+.+ ++++..+++++++.... ..+. .... .||.. .-+.+.+++.....+........|-.-+-+.-..
T Consensus 106 ~~~~~~l~~~~~~~~~~~~l~~~~-~~~ll~l~~~~~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~~~ 184 (478)
T PRK10189 106 AAARQSLVIMTLFAVLLAVLIHFF-GEQIIDLVAGDATPEVKALALTYLELTVWSYPAAAITLIGSGALRGAGNTKIPLL 184 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHh-HHHHHHHHhCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCchHHhHH
Confidence 344333 33444454444332211 1111 1111 23321 2234455555666666665555555555666666
Q ss_pred HHHHHHHHHHHHHHHHHHhccC--chhH----HHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCCCcc-c----Cccc
Q 018169 161 VETVATFSRCFTMCILIVKQYE--MEKG----IVFALSQVAYAASLFLGYWGYFLLFGAFKTSDLFPFRL-G----NMMS 229 (360)
Q Consensus 161 ~E~~a~~~~~~~~v~l~~~~~~--~~a~----~~fa~gql~~s~~~~~~y~~~~~~~~~~~~~~~~P~r~-~----~~~~ 229 (360)
+...+.+++.+..+.+.+...+ .+++ ++..++|.+..+.. .|+.+ .. . + ...+.+. + .+..
T Consensus 185 i~~~~~~~ni~l~~~li~g~~~~~~lGv~Gaa~At~is~~~~~~~~--~~~~~-~~--~-~--~~~~~~~~~~~~~~~~~ 256 (478)
T PRK10189 185 INGGMNILNIIISSILIYGLFSWQGLGFVGAGLGLTISRYIGAVAI--IWVLM-IG--F-N--PALRISLKSYFKPLNFA 256 (478)
T ss_pred HHHHHHHHHHHHhHHHHhcCCCCCccchHHHHHHHHHHHHHHHHHH--HHHHH-hc--c-C--ccceeeeccccccCCHH
Confidence 6666666666666665543211 1333 45555555543221 22221 10 0 0 0011110 0 0112
Q ss_pred ccHHHHHHHHHHHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhh
Q 018169 230 YDKQLANMCTLFTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKS 309 (360)
Q Consensus 230 ~~~~ll~~~~~~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~ 309 (360)
..+++++.+.+...+.+.-.+..=--..+++.+ +.+....|.++.|+-++.. ....-+..+.-+.=++....++.
T Consensus 257 ~~~~il~iG~P~~~~~~~~~~~~~~~~~~~~~~-G~~~~Aa~~I~~~i~~~~~-~~~~gi~~A~~~lvg~~~Ga~~~--- 331 (478)
T PRK10189 257 IIWEVMGIGIPASIESVLFNGGKLLTQMFVAGM-GTSVIAGNFIAFSIAALIN-LPGNALGSASTIITGTRLGKGQI--- 331 (478)
T ss_pred HHHHHHHHhccHHHHHHHHHHHHHHHHHHHHHc-CHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHhCCCCH---
Confidence 236777777776655444433221111122222 3456777888888776632 23333566666666666665544
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHhcccChHHHHHH
Q 018169 310 KKIGNSLAEALKLVLLIGMFFIELKFSLPIYEFNF 344 (360)
Q Consensus 310 ~~~~~~l~~~L~~~~~lgl~~~~~G~~~s~~ll~~ 344 (360)
++.++.....++....++++...+-...+++++++
T Consensus 332 ~~a~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~l 366 (478)
T PRK10189 332 AQAERQLRHVFWLSTLGLTAIAWLSAPFAGLLASF 366 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 35555555555555555544444333345555544
No 18
>COG0728 MviN Uncharacterized membrane protein, putative virulence factor [General function prediction only]
Probab=97.12 E-value=0.44 Score=49.39 Aligned_cols=324 Identities=12% Similarity=0.010 Sum_probs=163.7
Q ss_pred cchhhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHH----hHHHHHHHHHhcccCCCCcc
Q 018169 8 HSTSLSRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFL----SREGFRRACMRADIKCDGAS 83 (360)
Q Consensus 8 ~~~~~~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlfl----sre~~r~a~lr~~~~~~~~~ 83 (360)
-..++.|.+.......++||++.|+=-+++++.+.... .+-++......--++ .+-.+.+|.+-.=...++.+
T Consensus 5 ~~~sllks~~~vs~~Tl~SRi~G~vRd~~iA~~fGa~~---~aDAF~vAf~iPN~lRrlfaegafs~aFVPv~~~~~~~~ 81 (518)
T COG0728 5 SKMSLLKSLIIVSSATLLSRILGFVRDVLIAAAFGAGA---AADAFFVAFKLPNLLRRLFAEGAFSSAFVPVLAEAKKKE 81 (518)
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCch---HHHHHHHHHHhHHHHHHHHhchhHhhhhhHHHHHHHHcc
Confidence 34567788888899999999999999999999987732 333332222222222 22223444432111111111
Q ss_pred chhhHHHHHHHHHH-HHHHHHHHHHHHHHH---HH-HhhccccCCchh-hHH---HHHHHHHHHHhhhhhHHHHHHHhHh
Q 018169 84 REENAAKLLKVAWL-TLPLGIFITIGACFF---VL-WWQGLSYSNPYA-QAI---FINGFACVLELLAEPLYILSQNLLL 154 (360)
Q Consensus 84 ~~~~~~~~~n~awl-~i~~g~~~~~~~~~~---~~-~~~~~~~~~~~~-~~~---~~~~ls~iie~l~eP~~~~~qr~l~ 154 (360)
+++....+...... ...+.++++++..+. .. .......++++. ... .+.---.++-.+..-...+.|..-+
T Consensus 82 ~~~~~~~f~~~v~~~l~~~ll~vt~L~~l~~p~iv~~~~~~g~~~~~~~~a~~l~~i~~Pyl~~isL~al~~aiLNs~~~ 161 (518)
T COG0728 82 GEEAARFFSRLVTGLLTLVLLLVTLLGILFAPWLVRLLLAPGFDETDKFLAVLLTRILFPYLLFISLSALFGAILNSRNR 161 (518)
T ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCe
Confidence 11122222222110 011111222221111 11 111111122221 111 1222222222333333344444444
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHH-HhccCchh-HHHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCCCcccCcccccH
Q 018169 155 LRLRLVVETVATFSRCFTMCILI-VKQYEMEK-GIVFALSQVAYAASLFLGYWGYFLLFGAFKTSDLFPFRLGNMMSYDK 232 (360)
Q Consensus 155 ~~~r~~~E~~a~~~~~~~~v~l~-~~~~~~~a-~~~fa~gql~~s~~~~~~y~~~~~~~~~~~~~~~~P~r~~~~~~~~~ 232 (360)
|..-+.....-. +..++.. +..+..+. .++.++|-++.++.-+...+.+.+..+ .. .-|+++.++. --|
T Consensus 162 F~~~a~aPvl~N----v~~I~~~l~~~~~~~~~~~~La~gvl~Gg~~Q~l~~lp~l~~~g-~~---~~p~~~~~~~-~lk 232 (518)
T COG0728 162 FFIPAFAPVLLN----VSVIGLALFLGPYFDPPLLALAWGVLIGGLLQLLVQLPALRKAG-LL---IKPRFGFKDP-GLK 232 (518)
T ss_pred echhhhhHHHHH----HHHHHHHHHhccchhhHHHHHHHHHHHHHHHHHHHHHHHHHHcc-cc---cCCCCCCCch-hHH
Confidence 444443333333 3333222 22232233 466667777776654433322222211 01 1122211111 115
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhhhHH
Q 018169 233 QLANMCTLFTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKSKKI 312 (360)
Q Consensus 233 ~ll~~~~~~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~~~~ 312 (360)
++...........-..|++.--|..+-+...+ ...-.+.-++-+=.+|--++---+-....|..||...+++. ++.
T Consensus 233 ~~~~~~~p~~l~~sisQi~lli~~~iAS~l~~-Gsis~l~YA~rl~qlPlGifgvai~tvllP~lSr~~~~~~~---~~~ 308 (518)
T COG0728 233 RFLKLMLPALLGVSISQINLLIDTAIASFLAE-GSVSWLYYADRLYQLPLGIFGVALSTVLLPSLSRHAANGDW---PEF 308 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcc-ccHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHhhcCCh---HHH
Confidence 56666666677777788877777665554432 23334555655666666666666788889999999877543 356
Q ss_pred HHHHHHHHHHHHHHHHHHHHhcccChHHHHHHHhc
Q 018169 313 GNSLAEALKLVLLIGMFFIELKFSLPIYEFNFVVK 347 (360)
Q Consensus 313 ~~~l~~~L~~~~~lgl~~~~~G~~~s~~ll~~llG 347 (360)
.+.+..-+|...++.++...+....|+++++++|.
T Consensus 309 ~~~l~~~i~l~lll~lP~~~~l~~la~piv~~Lf~ 343 (518)
T COG0728 309 LKLLDWGLRLTLLLTLPASAGLLVLAEPIVSLLFE 343 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc
Confidence 67777789999999999999888899999999997
No 19
>PRK10459 colanic acid exporter; Provisional
Probab=95.07 E-value=4 Score=41.51 Aligned_cols=174 Identities=14% Similarity=0.064 Sum_probs=85.0
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHHHH----HhcccCCCCccchhhH
Q 018169 13 SRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRRAC----MRADIKCDGASREENA 88 (360)
Q Consensus 13 ~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~a~----lr~~~~~~~~~~~~~~ 88 (360)
.+=..|.+..++...+.+-.-+.++.+.++|++.|..+.+..+.......++- .+.... -|.+++++ +-++..
T Consensus 210 l~~~~~~~~~~~~~~~~~~~d~~~lg~~lg~~~vG~Y~~A~~l~~~~~~~i~~-~i~~v~~P~~s~~~~~~~--~~~~~~ 286 (492)
T PRK10459 210 LSFGAWQTAERIINYLNTNIDTILIGRILGAEVLGGYNLAYNVATVPPMKINP-IITRVAFPVFAKIQDDTE--KLRVGF 286 (492)
T ss_pred HhhhHHHHHHHHHHHHHhcCchhhhhHhhchHhhhhHHHHHHHHHHHHHHHHH-HHHHHHhHHHHHhcCCHH--HHHHHH
Confidence 33344677777777777777778889999999999998877654332222221 222211 12211110 001112
Q ss_pred HHHHHHH-HHHHHHHHHHHHHHHHHHHHhhccccCCch---hhHHHHHHHHHHHHhhhhhHHHHHHHhHhHHHHHHHHHH
Q 018169 89 AKLLKVA-WLTLPLGIFITIGACFFVLWWQGLSYSNPY---AQAIFINGFACVLELLAEPLYILSQNLLLLRLRLVVETV 164 (360)
Q Consensus 89 ~~~~n~a-wl~i~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~~~E~~ 164 (360)
.+..+.. +..+|..+.+.+..--+ ....+++.| .+.+.++++..++..+..|.....+-.-+.+.-.+.+..
T Consensus 287 ~~~~~~~~~~~~p~~~~l~~~a~~i----i~ll~g~~~~~a~~~l~il~~~~~~~~~~~~~~~~l~a~g~~~~~~~~~~~ 362 (492)
T PRK10459 287 LKLLSVLGIINFPLLLGLMVVSNNF----VPLVFGEKWNSAIPILQLLCIVGLLRSVGNPIGSLLLAKGRADLSFKWNVF 362 (492)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhHHH----HHHhcChhHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHcCccchhHHHHHH
Confidence 2233322 22344333222221110 112234444 245677888888888888876555544444544445544
Q ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHH
Q 018169 165 ATFSRCFTMCILIVKQYEMEKGIVFALSQVAYA 197 (360)
Q Consensus 165 a~~~~~~~~v~l~~~~~~~~a~~~fa~gql~~s 197 (360)
..++.....+. ....+++.+.+++..+..
T Consensus 363 ~~~~~i~~~~~----~~~~~G~~g~a~a~~i~~ 391 (492)
T PRK10459 363 KTFLFIPAIVI----GGQLAGLIGVALGFLLVQ 391 (492)
T ss_pred HHHHHHHHHHH----HHhhccHHHHHHHHHHHH
Confidence 43332222221 112234555555555543
No 20
>COG2244 RfbX Membrane protein involved in the export of O-antigen and teichoic acid [General function prediction only]
Probab=94.74 E-value=4.7 Score=40.69 Aligned_cols=163 Identities=21% Similarity=0.188 Sum_probs=100.4
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHHHHHhcccCCCCccchhhHHHH
Q 018169 12 LSRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRRACMRADIKCDGASREENAAKL 91 (360)
Q Consensus 12 ~~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~a~lr~~~~~~~~~~~~~~~~~ 91 (360)
..+-............+.+-.=+.++.+.++|++.|+.+. ...+.....++.. ++..++.-.-....+.+++...++.
T Consensus 215 ~l~~~~p~~~~~~~~~l~~~~D~~~i~~~l~~~~vG~Y~~-a~~i~~~~~~~~~-~l~~~l~P~~s~~~~~~~~~~~~~~ 292 (480)
T COG2244 215 LLRFGLPLLLSSLLNFLFTNIDTLLLGLFLGPAQVGIYSA-AQRLVSLLLIVAS-ALNRVLFPALSRAYAEGDRKALKKL 292 (480)
T ss_pred HHHHhhHHHHHHHHHHHHHHHHHHHHHHHhhhhHheeccc-ccHHHHHHHHHHH-HHHHHHHHHHHHHHHcCcHHHHHHH
Confidence 4444556777788888888899999999999999999994 4444444445544 6666655321111000111111112
Q ss_pred HH--HHHHHHHHHHHHHHHHHHHHHH-hh-ccccCCch---hhHHHHHHHHHHHHhhhhhHHHHHHHhHhHHHHHHHHHH
Q 018169 92 LK--VAWLTLPLGIFITIGACFFVLW-WQ-GLSYSNPY---AQAIFINGFACVLELLAEPLYILSQNLLLLRLRLVVETV 164 (360)
Q Consensus 92 ~n--~awl~i~~g~~~~~~~~~~~~~-~~-~~~~~~~~---~~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~~~E~~ 164 (360)
.+ +.++ ...+++..+.+.. .. +. ...++++| ...+.+++++.++..+.+|.....|-.-+.+...+....
T Consensus 293 ~~~~~~~~-~~~~~p~~~~l~~--~~~~~i~~~fg~~~~~~~~~l~il~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~ 369 (480)
T COG2244 293 LRQSLKLL-LLISIPALLGLLL--LAPPIITLLFGEKYASAAPILQLLALAGLFLSLVSLTSSLLQALGKQRLLLLISLI 369 (480)
T ss_pred HHHHHHHH-HHHHHHHHHHHHH--HHhhhheeecCCcccchhHHHHHHHHHHHHHHHHHHHHHHHHHcCcchhhHHHHHH
Confidence 22 2222 1222222222111 22 11 23355555 357799999999999999999999988888888888888
Q ss_pred HHHHHHHHHHHHHHh
Q 018169 165 ATFSRCFTMCILIVK 179 (360)
Q Consensus 165 a~~~~~~~~v~l~~~ 179 (360)
+.+.+.+..+.+...
T Consensus 370 ~~i~~~~l~~~li~~ 384 (480)
T COG2244 370 SALLNLILNLLLIPR 384 (480)
T ss_pred HHHHHHHHHhHHHHh
Confidence 888888887776443
No 21
>PRK15099 O-antigen translocase; Provisional
Probab=94.53 E-value=5.5 Score=39.56 Aligned_cols=45 Identities=11% Similarity=0.061 Sum_probs=38.2
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHH
Q 018169 11 SLSRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHL 55 (360)
Q Consensus 11 ~~~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l 55 (360)
++.+-..+.+..++...+.+...|.++.+..++++-|..+++..+
T Consensus 216 ~ll~~g~p~~~~~~~~~i~~~~~~~~l~~~~g~~~vg~y~~a~~i 260 (416)
T PRK15099 216 QLGKFTLMALITSVTLPVAYVMMRNLLAAHYSWDEVGIWQGVSSI 260 (416)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHhhHHHHHHHH
Confidence 455556688888999999999999999999999999999877664
No 22
>TIGR00797 matE putative efflux protein, MATE family. The MATE family consists of probable efflux proteins including a functionally characterized multi drug efflux system from Vibrio parahaemolyticus, a putative ethionine resistance protein of Saccharomyces cerevisiae, and the functionally uncharacterized DNA damage-inducible protein F (DinF) of E. coli. These proteins have 12 probable TMS.
Probab=93.99 E-value=0.17 Score=48.64 Aligned_cols=101 Identities=14% Similarity=0.170 Sum_probs=79.9
Q ss_pred HHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhhhHHHHHHHHHH
Q 018169 241 FTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKSKKIGNSLAEAL 320 (360)
Q Consensus 241 ~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~~~~~~~l~~~L 320 (360)
.+.++++.++..-.|+++++.+. .++.|.|+++..+.. +.+.+...+..+..+..++...++++ ++.++.+...+
T Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~g-~~~~~~~~~a~~i~~-~~~~~~~~i~~~~~~~~s~~~g~~~~---~~~~~~~~~~~ 76 (342)
T TIGR00797 2 AILANILQPLLGLVDTAFVGHLG-PVDLAAVSLGSSVFM-FLFSILMGLGTATTALVAQAVGAGNY---QRLGRQAQQSL 76 (342)
T ss_pred hHHHHHHHHHHHHHHHHHHhccc-HHHHHHHHHhHHHHH-HHHHHHHHHHHhHHHHHHHHHCCCCh---HHHHHHHHHHH
Confidence 45677888888899999999965 678999999977644 67788888999999999998766533 35666777788
Q ss_pred HHHHHHHHHHHHhcccChHHHHHHHhc
Q 018169 321 KLVLLIGMFFIELKFSLPIYEFNFVVK 347 (360)
Q Consensus 321 ~~~~~lgl~~~~~G~~~s~~ll~~llG 347 (360)
+....+++++..+....++++.++ +|
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~-~~ 102 (342)
T TIGR00797 77 LLALLLGLPVLLVGYFFIDPLLSL-MG 102 (342)
T ss_pred HHHHHHHHHHHHHHHHhHHHHHHH-hC
Confidence 888888888887777788888865 44
No 23
>PRK01766 multidrug efflux protein; Reviewed
Probab=93.73 E-value=0.26 Score=49.76 Aligned_cols=111 Identities=9% Similarity=0.055 Sum_probs=83.4
Q ss_pred cHHHHHHHHHHHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhhh
Q 018169 231 DKQLANMCTLFTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKSK 310 (360)
Q Consensus 231 ~~~ll~~~~~~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~~ 310 (360)
-|++++++.+...+++...+..--|.++++++ +.++++.++++.++-.. .-.+..-+....-+.-|+....++. +
T Consensus 11 ~~~il~~~~P~~~~~~~~~~~~~~d~~~i~~~-g~~~laa~~~~~~~~~~-~~~~~~g~~~a~~~~vs~~~g~~~~---~ 85 (456)
T PRK01766 11 ARQLLALALPILLAQVAQTAMGFVDTVMAGGV-SATDLAAVAIGTSIWLP-VILFGHGLLLALTPIVAQLNGAGRR---E 85 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcc-CHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHhcCCCh---H
Confidence 37899999999999999999999999999986 55678888888766332 2334444666777777777766433 4
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhcccChHHHHHHHh
Q 018169 311 KIGNSLAEALKLVLLIGMFFIELKFSLPIYEFNFVV 346 (360)
Q Consensus 311 ~~~~~l~~~L~~~~~lgl~~~~~G~~~s~~ll~~ll 346 (360)
+.++.+..-++....++++..++....++++++++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~ 121 (456)
T PRK01766 86 RIAHQVRQGLWLALFLSVLIMLVLYNAVPPILNMMN 121 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHcC
Confidence 566777778888888888777766667788887643
No 24
>PRK09575 vmrA multidrug efflux pump VmrA; Reviewed
Probab=91.90 E-value=0.95 Score=45.88 Aligned_cols=112 Identities=11% Similarity=-0.034 Sum_probs=86.1
Q ss_pred ccHHHHHHHHHHHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhh
Q 018169 230 YDKQLANMCTLFTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKS 309 (360)
Q Consensus 230 ~~~~ll~~~~~~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~ 309 (360)
..|++++++.+...++++..+.+=-|.++++++.+.++.+.|++++.+-.+.. .+..=+...+-+.-++....++.
T Consensus 10 ~~k~i~~l~~P~~~~~l~~~l~~~~d~~~lg~~~g~~~laa~~~~~~~~~~~~-~~~~~~~~g~~~lvsq~~Ga~~~--- 85 (453)
T PRK09575 10 IYRTFWRYTIPSIAAMLVNGLYQIVDGIFIGHYVGAEGLAGINMAWPVIGIIL-GIGLMVGMGTGSLLSIKRGEGDL--- 85 (453)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcccccHHHHHHHHHHHHHHHHHH-HHHHHHhccHHHHHHHHhcCCCH---
Confidence 34899999999999999999999999999999988888888888766644432 22223444555677777765533
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHhcccChHHHHHHH
Q 018169 310 KKIGNSLAEALKLVLLIGMFFIELKFSLPIYEFNFV 345 (360)
Q Consensus 310 ~~~~~~l~~~L~~~~~lgl~~~~~G~~~s~~ll~~l 345 (360)
++.++.+...++....+++++..+....++++++++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~l~ 121 (453)
T PRK09575 86 EKAKRILTTGLLLLLLLGPIVSVILFLFADDFLRAQ 121 (453)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 467777777888888888888877777889988764
No 25
>TIGR02900 spore_V_B stage V sporulation protein B. SpoVB is the stage V sporulation protein B of the bacterial endopore formation program in Bacillus subtilis and various other Firmcutes. It is nearly universal among endospore-formers. Paralogs with rather high sequence similarity to SpoVB exist, including YkvU in B. subtilis and a number of proteins in the genus Clostridium. Member sequences for the seed alignment were chosen to select those proteins, no more than one to a genome, closest to B. subtilis SpoVB in a neighbor joining tree.
Probab=91.66 E-value=16 Score=36.73 Aligned_cols=68 Identities=12% Similarity=0.065 Sum_probs=42.3
Q ss_pred hHHHHHHHHHHHHhhhhhHHHHHHHhHhHHHHHHHHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHH
Q 018169 127 QAIFINGFACVLELLAEPLYILSQNLLLLRLRLVVETVATFSRCFTMCILIVKQYEMEKGIVFALSQVAY 196 (360)
Q Consensus 127 ~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~~~E~~a~~~~~~~~v~l~~~~~~~~a~~~fa~gql~~ 196 (360)
..+.+++++.++..+..+.....+-.-+-+...+....+.+++.+..+.+... + .+++.+.+++..+.
T Consensus 352 ~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~i~~i~l~~~l~~~-~-~~G~~Gaaia~~i~ 419 (488)
T TIGR02900 352 NFIRVLAPSFPFLYFSAPLQSILQGLGKQKVALRNSLIGAIVKIILLFVLTSI-P-SINIYGYAITFIIT 419 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhcCcchHHHHHHHHHHHHHHHHHHHHHhc-c-ccccHHHHHHHHHH
Confidence 45677888888888888876666665566777777777777766665554321 1 23344444444443
No 26
>PF01554 MatE: MatE; InterPro: IPR002528 Characterised members of the Multi Antimicrobial Extrusion (MATE) family function as drug/sodium antiporters. These proteins mediate resistance to a wide range of cationic dyes, fluroquinolones, aminoglycosides and other structurally diverse antibodies and drugs. MATE proteins are found in bacteria, archaea and eukaryotes. These proteins are predicted to have 12 alpha-helical transmembrane regions, some of the animal proteins may have an additional C-terminal helix. ; GO: 0015238 drug transmembrane transporter activity, 0015297 antiporter activity, 0006855 drug transmembrane transport, 0055085 transmembrane transport, 0016020 membrane; PDB: 3MKU_B 3MKT_B.
Probab=91.65 E-value=0.14 Score=43.48 Aligned_cols=99 Identities=13% Similarity=0.220 Sum_probs=76.6
Q ss_pred HHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhhhHHHHHHHHHH
Q 018169 241 FTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKSKKIGNSLAEAL 320 (360)
Q Consensus 241 ~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~~~~~~~l~~~L 320 (360)
...++++..+....|..+++++ +.++.+.|+++.++.++. ..+..-+.++.-+.-++...+++.+ +.++.+...+
T Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~-g~~~~a~~~i~~~~~~~~-~~~~~g~~~a~~~~~s~~~G~~~~~---~~~~~~~~~~ 76 (162)
T PF01554_consen 2 IALMQLLQVLGFIIDTIFVGRL-GPEALAAYGIASSIFSIL-FMLIFGLATALQILISQNIGAGDYK---RAKKVVRQGL 76 (162)
T ss_dssp HHHHHHHHHHHHHHHHHCCHCC-TTCCCCHCCHHHHHHHHH-HHHHHHHHHHHHHHHCCCCCSSSTT---TCCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHh-CHHHHHHHHHHHHHHHHH-hhhcccccccccceeeccccccccc---cccccccccc
Confidence 4567888888899999999999 999999999999998874 4467777888888888777665444 4445666678
Q ss_pred HHHHHHHHHHHHhcccChHHHHHH
Q 018169 321 KLVLLIGMFFIELKFSLPIYEFNF 344 (360)
Q Consensus 321 ~~~~~lgl~~~~~G~~~s~~ll~~ 344 (360)
+....++++...+....++++.++
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~ 100 (162)
T PF01554_consen 77 LLSLIIGLLLSLVLLLFSEFILSL 100 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCHCT
T ss_pred ccchhcccchhhhhhhHHHHHHHH
Confidence 888888887777766667776665
No 27
>PRK10189 MATE family multidrug exporter; Provisional
Probab=89.63 E-value=0.87 Score=46.67 Aligned_cols=113 Identities=13% Similarity=0.205 Sum_probs=86.3
Q ss_pred cccHHHHHHHHHHHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchh
Q 018169 229 SYDKQLANMCTLFTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQK 308 (360)
Q Consensus 229 ~~~~~ll~~~~~~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~ 308 (360)
.+.|++++++.+...++++..+..=-|.++++++ +.++...+++++++-.+ .-.+..=+....-+.-++....++.
T Consensus 26 ~~~k~il~la~P~~~~~~~~~~~~~vd~~~vg~l-G~~alAA~~i~~~i~~~-~~~~~~gl~~g~~~lvsq~~Ga~~~-- 101 (478)
T PRK10189 26 LFWREITPLAVPIFIENLCVLLMGVLSTFLVSWL-GKEAMAGVGLADSFNMV-IMAFFAAIDLGTTVVVAFSLGKRDR-- 101 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc-CHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHhcCCCH--
Confidence 4468999999999999999999999999999985 56788888888887544 2333334566666777777766543
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHHhcccChHHHHHHHh
Q 018169 309 SKKIGNSLAEALKLVLLIGMFFIELKFSLPIYEFNFVV 346 (360)
Q Consensus 309 ~~~~~~~l~~~L~~~~~lgl~~~~~G~~~s~~ll~~ll 346 (360)
++.++.....+.....++++...+....++++++++-
T Consensus 102 -~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ll~l~~ 138 (478)
T PRK10189 102 -RRARAAARQSLVIMTLFAVLLAVLIHFFGEQIIDLVA 138 (478)
T ss_pred -HHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHh
Confidence 4666777767777777888777777778888888754
No 28
>PRK10367 DNA-damage-inducible SOS response protein; Provisional
Probab=89.57 E-value=1.9 Score=43.62 Aligned_cols=110 Identities=20% Similarity=0.224 Sum_probs=82.5
Q ss_pred cHHHHHHHHHHHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhhh
Q 018169 231 DKQLANMCTLFTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKSK 310 (360)
Q Consensus 231 ~~~ll~~~~~~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~~ 310 (360)
.|++++++.+...++++..+.+=-|.+++|++.+.++...+++++++-+...-. +.=+--..-+.-||....++. +
T Consensus 8 ~k~il~la~P~~~~~~~~~~~~~vd~~~vg~l~g~~alAa~~l~~~i~~~~~~~-~~~~~~g~~~lvsq~~Ga~~~---~ 83 (441)
T PRK10367 8 DKALWRLALPMIFSNITVPLLGLVDTAVIGHLDSPVYLGGVAVGATATSFLFML-LLFLRMSTTGLTAQAFGAKNP---Q 83 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHhCCCCH---H
Confidence 378999999999999999999999999999987777788888887765554322 222444555566666655433 4
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhcccChHHHHHH
Q 018169 311 KIGNSLAEALKLVLLIGMFFIELKFSLPIYEFNF 344 (360)
Q Consensus 311 ~~~~~l~~~L~~~~~lgl~~~~~G~~~s~~ll~~ 344 (360)
+.++.+...+.....++++...++....++++++
T Consensus 84 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ll~~ 117 (441)
T PRK10367 84 ALARALVQPLLLALGAGALIALLRTPLIDLALHI 117 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 6667777777788888887777877777887765
No 29
>TIGR01695 mviN integral membrane protein MviN. This model represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII.
Probab=87.80 E-value=33 Score=34.66 Aligned_cols=159 Identities=11% Similarity=0.031 Sum_probs=79.8
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHHHHH---hcccCCCCccchhhH
Q 018169 12 LSRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRRACM---RADIKCDGASREENA 88 (360)
Q Consensus 12 ~~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~a~l---r~~~~~~~~~~~~~~ 88 (360)
..+-..+....++...+.+.+-+ .+.+.++++..|..+.+..+.......+.- ++..+.. .+..++ +|.+..
T Consensus 225 ~l~~~~p~~~~~~~~~~~~~id~-~~~~~~~~~~v~~~~~a~~l~~~~~~~~~~-~i~~~~~P~~s~~~~~---~~~~~~ 299 (502)
T TIGR01695 225 FLKLFLPTTLGSSASQITLLINT-ALASFLEIGSVSALYYANRIYQLPLGIFGI-SLSTVLLPKLSRHASE---GNWNEL 299 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHH-HHHhcCCcchHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHhc---CCHHHH
Confidence 44444456666777766666655 458899998888777654433221111221 3343332 111111 111122
Q ss_pred HHHHHHH-HHHHHHHHHHHHHHHHHHHHhh-ccccC----C--ch---hhHHHHHHHHHHHHhhhhhHHHHHHHhHhHHH
Q 018169 89 AKLLKVA-WLTLPLGIFITIGACFFVLWWQ-GLSYS----N--PY---AQAIFINGFACVLELLAEPLYILSQNLLLLRL 157 (360)
Q Consensus 89 ~~~~n~a-wl~i~~g~~~~~~~~~~~~~~~-~~~~~----~--~~---~~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~ 157 (360)
++..+.+ .....+++++++.+... .-+. ...++ + .+ ...+.+++++.+..++..+.....+-.-+.+.
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~l~~~-~~~ii~l~~~~~~f~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~a~g~~~~ 378 (502)
T TIGR01695 300 RDLLNQGIRLSLLLTIPSSFGLLIL-SIPIVSLLFERGAFSEEDTVMTATILAAYGLGLIFYSLQKVLLRAFYARKDTRT 378 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhccCCcc
Confidence 3333322 22233333333332221 1111 11122 1 12 24567788888888888887766666566676
Q ss_pred HHHHHHHHHHHHHHHHHHH
Q 018169 158 RLVVETVATFSRCFTMCIL 176 (360)
Q Consensus 158 r~~~E~~a~~~~~~~~v~l 176 (360)
-...+....+++....+.+
T Consensus 379 ~~~~~~~~~~i~i~l~~~l 397 (502)
T TIGR01695 379 PFINSVISVVLNALLSLLL 397 (502)
T ss_pred CHHHHHHHHHHHHHHHHHH
Confidence 7777777766666655544
No 30
>PF01554 MatE: MatE; InterPro: IPR002528 Characterised members of the Multi Antimicrobial Extrusion (MATE) family function as drug/sodium antiporters. These proteins mediate resistance to a wide range of cationic dyes, fluroquinolones, aminoglycosides and other structurally diverse antibodies and drugs. MATE proteins are found in bacteria, archaea and eukaryotes. These proteins are predicted to have 12 alpha-helical transmembrane regions, some of the animal proteins may have an additional C-terminal helix. ; GO: 0015238 drug transmembrane transporter activity, 0015297 antiporter activity, 0006855 drug transmembrane transport, 0055085 transmembrane transport, 0016020 membrane; PDB: 3MKU_B 3MKT_B.
Probab=86.07 E-value=1.4 Score=37.19 Aligned_cols=83 Identities=17% Similarity=0.218 Sum_probs=47.0
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhHHHHHHHHHh---cccCCCCccchhhHHHHH-HHH
Q 018169 20 LATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSREGFRRACMR---ADIKCDGASREENAAKLL-KVA 95 (360)
Q Consensus 20 i~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsre~~r~a~lr---~~~~~~~~~~~~~~~~~~-n~a 95 (360)
++.++...+...+.+.++.|+ +|++.+..++...+......+. .|+..+... +..++++ .++.++.+ ...
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~-g~~~~a~~~i~~~~~~~~~~~~--~g~~~a~~~~~s~~~G~~~---~~~~~~~~~~~~ 76 (162)
T PF01554_consen 3 ALMQLLQVLGFIIDTIFVGRL-GPEALAAYGIASSIFSILFMLI--FGLATALQILISQNIGAGD---YKRAKKVVRQGL 76 (162)
T ss_dssp HHHHHHHHHHHHHHHHCCHCC-TTCCCCHCCHHHHHHHHHHHHH--HHHHHHHHHHHCCCCCSSS---TTTCCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHh-CHHHHHHHHHHHHHHHHHhhhc--ccccccccceeeccccccc---cccccccccccc
Confidence 345666777777777777777 9999998888766544443322 477766553 3332221 11222233 333
Q ss_pred HHHHHHHHHHHHH
Q 018169 96 WLTLPLGIFITIG 108 (360)
Q Consensus 96 wl~i~~g~~~~~~ 108 (360)
++++..|++++++
T Consensus 77 ~~~~~~~~~~~~~ 89 (162)
T PF01554_consen 77 LLSLIIGLLLSLV 89 (162)
T ss_dssp HHHHHHHHHHHHH
T ss_pred ccchhcccchhhh
Confidence 4455666666554
No 31
>PRK00187 multidrug efflux protein NorA; Provisional
Probab=84.60 E-value=5 Score=40.83 Aligned_cols=110 Identities=14% Similarity=0.024 Sum_probs=83.2
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhhhH
Q 018169 232 KQLANMCTLFTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKSKK 311 (360)
Q Consensus 232 ~~ll~~~~~~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~~~ 311 (360)
|++++++.+...+++...+..=.|.++++++ +.++++.++++..+-+... .+..-+-.+.-+.-|+....++. ++
T Consensus 10 k~il~~a~P~~~~~~~~~~~~~~d~~~v~~l-g~~alAa~~i~~~i~~~~~-~~~~gl~~~~~~i~aq~~Ga~~~---~~ 84 (464)
T PRK00187 10 KAILRLAGPLIASQLAHMLMVFTDTLMMGRL-GPEALAGGGLGAASYSFVS-IFCVGVIAAVGTLVAIRHGAGDI---EG 84 (464)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhcc-CHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHhcCCCh---hh
Confidence 7899999999999999999999999999996 5678889999888766543 44455667777888888776544 36
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhcccChHHHHHHHhcC
Q 018169 312 IGNSLAEALKLVLLIGMFFIELKFSLPIYEFNFVVKG 348 (360)
Q Consensus 312 ~~~~l~~~L~~~~~lgl~~~~~G~~~s~~ll~~llG~ 348 (360)
.++.+..-+.....++++...+.. .+++++++ +|.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~il~l-~~~ 119 (464)
T PRK00187 85 ATRLAQAGLWLAWLLALVAALLLW-NLKPLLLL-FGQ 119 (464)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHH-cCC
Confidence 667776677777777766655433 56787775 454
No 32
>PF07260 ANKH: Progressive ankylosis protein (ANKH); InterPro: IPR009887 This family consists of several progressive ankylosis protein (ANK or ANKH) sequences. The ANK protein spans the outer cell membrane and shuttles inorganic pyrophosphate (PPi), a major inhibitor of physiologic and pathologic calcification, bone mineralisation and bone resorption []. Mutations in ANK are thought to give rise to Craniometaphyseal dysplasia (CMD) which is a rare skeletal disorder characterised by progressive thickening and increased mineral density of craniofacial bones and abnormally developed metaphyses in long bones [].; GO: 0015114 phosphate ion transmembrane transporter activity, 0035435 phosphate ion transmembrane transport, 0016021 integral to membrane
Probab=81.03 E-value=58 Score=31.87 Aligned_cols=211 Identities=10% Similarity=0.045 Sum_probs=106.6
Q ss_pred HHHHHHHHHhhChh-----hhHHHHHHHHHHHHHHHHHhHHHHHHHHHhcccCCCCccchhhHHHHHHHHHHH-HHHHHH
Q 018169 31 FVFNSWIVRHLTEA-----DYAIYAVQFHLFVTCVLFLSREGFRRACMRADIKCDGASREENAAKLLKVAWLT-LPLGIF 104 (360)
Q Consensus 31 F~~n~iL~R~LsP~-----~fGi~av~l~l~~~tvlflsre~~r~a~lr~~~~~~~~~~~~~~~~~~n~awl~-i~~g~~ 104 (360)
=+.|--++|...++ .|| +|..+.++..+- +..-+-+..+.++++++. .-+|.. +..|+.
T Consensus 32 qiiNagLAr~~e~~vetLAsfg-lA~sL~lf~~sp-~~~~~~igl~~V~s~rsr-------------r~~vl~~~vag~v 96 (345)
T PF07260_consen 32 QIINAGLARVQEDPVETLASFG-LAYSLMLFFASP-LSMFHHIGLVFVNSKRSR-------------RKAVLCMAVAGAV 96 (345)
T ss_pred HHHHHHHhhccchHHHHHHHHH-HHHHHHHHHhCh-hhhhHHHHHHHhcchhhh-------------HHHHHHHHHHHHH
Confidence 36788899854333 466 455555444443 223357777777775432 113331 233544
Q ss_pred HHHHHHHHHHHhh--cc-----ccCCch-----hhHHHHHHHHHHHHhhhhhHHHHHHHhHhHHHHHHHHHHHHHHHHHH
Q 018169 105 ITIGACFFVLWWQ--GL-----SYSNPY-----AQAIFINGFACVLELLAEPLYILSQNLLLLRLRLVVETVATFSRCFT 172 (360)
Q Consensus 105 ~~~~~~~~~~~~~--~~-----~~~~~~-----~~~~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~~~E~~a~~~~~~~ 172 (360)
.+.+..++ .+.+ +. ...+|. ..+.....+=++++++..-+.-+.-|+ +...-+..+..+.++.-++
T Consensus 97 ~avi~~LI-a~TpLG~~li~~lhgVs~~va~~tr~a~l~L~llPfl~alr~~~qGILik~-r~s~iV~~aSI~~v~~qvV 174 (345)
T PF07260_consen 97 AAVIHLLI-AWTPLGNYLINDLHGVSPSVAEKTRRAFLYLTLLPFLDALRWIHQGILIKH-RHSWIVGSASIADVIAQVV 174 (345)
T ss_pred HHHHHHHH-HhCchHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhhhc-cceeEeehHHHHHHHHHHH
Confidence 44332222 1111 00 112221 245666777777777777775444443 3333333444443333333
Q ss_pred HHHHHHhc--cCch----hHHHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCCCcccC---cccccHHHHHHHHHHHH
Q 018169 173 MCILIVKQ--YEME----KGIVFALSQVAYAASLFLGYWGYFLLFGAFKTSDLFPFRLGN---MMSYDKQLANMCTLFTF 243 (360)
Q Consensus 173 ~v~l~~~~--~~~~----a~~~fa~gql~~s~~~~~~y~~~~~~~~~~~~~~~~P~r~~~---~~~~~~~ll~~~~~~~~ 243 (360)
.+...... +..+ ++++.-.|..+..-++.++|+.-. .+..|.+++. ....-+++++|.+.+..
T Consensus 175 ~v~~ll~~~l~~~~pllipil~~y~g~~vr~t~v~LGy~~~i--------~~~~p~~~~~~~~~~~tl~~~l~F~~PL~~ 246 (345)
T PF07260_consen 175 LVAILLSMHLEPQDPLLIPILALYAGIAVRFTIVCLGYYQSI--------HDIIPQLSGLEKGDSATLQRMLKFWWPLAL 246 (345)
T ss_pred HHHHHHccccCccccHHHHHHHHHHHHHHHHHHHHHHHHHHH--------hhhccccCCcccCCChhHHHHHHHHHHHHH
Confidence 33222211 1112 224555566665444446776321 2334555332 22333789999999998
Q ss_pred HHHHHHHHhhhceeeeEeccCCC
Q 018169 244 QSFRKLLLQEGEKLVLVWLDTPY 266 (360)
Q Consensus 244 qsi~k~lltegDk~vl~~~~~~~ 266 (360)
.....+..+--=++.+++-.+-+
T Consensus 247 ~~~tq~~SrplVnl~vsR~l~gs 269 (345)
T PF07260_consen 247 VLATQRISRPLVNLFVSRDLSGS 269 (345)
T ss_pred HHHHHHHHHHHHHHHHhhccCCc
Confidence 88888777777777777755433
No 33
>COG0534 NorM Na+-driven multidrug efflux pump [Defense mechanisms]
Probab=72.75 E-value=19 Score=36.73 Aligned_cols=113 Identities=17% Similarity=0.205 Sum_probs=81.7
Q ss_pred ccHHHHHHHHHHHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhhhcCCCchhh
Q 018169 230 YDKQLANMCTLFTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARSASGQYPQKS 309 (360)
Q Consensus 230 ~~~~ll~~~~~~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~~~~~~~~~~ 309 (360)
..|+++++..+...++++..+.+=-|.+++|++. .++.+.=++++.+=.++. .++.=+.-.+-+..||....++ .
T Consensus 15 ~~k~l~~la~P~i~~~l~~~l~~~vD~~~vG~~~-~~alaav~la~~i~~~~~-~~~~gl~~g~~~liaq~~Ga~~---~ 89 (455)
T COG0534 15 ILKLLLKLAIPIILGNLLQTLYGLVDTFMVGHLG-AEALAAVGLANPIFFLII-AIFIGLGTGTTVLVAQAIGAGD---R 89 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccc-HHHHHHHHHHHHHHHHHH-HHHHHHHHhHHHHHHHHHcCCc---h
Confidence 4589999999999999999999999999999998 444444444433322211 1112244456666677765543 3
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHhcccChHHHHHHHhc
Q 018169 310 KKIGNSLAEALKLVLLIGMFFIELKFSLPIYEFNFVVK 347 (360)
Q Consensus 310 ~~~~~~l~~~L~~~~~lgl~~~~~G~~~s~~ll~~llG 347 (360)
++.++++...+-....+|++....+...++++++++-+
T Consensus 90 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ll~~l~~ 127 (455)
T COG0534 90 KKAKRVLGQGLLLALLLGLLLAILLLFFAEPLLRLLGA 127 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 46777777788888888988888888889999999665
No 34
>PF13440 Polysacc_synt_3: Polysaccharide biosynthesis protein
Probab=64.66 E-value=7.7 Score=34.92 Aligned_cols=37 Identities=19% Similarity=0.267 Sum_probs=29.6
Q ss_pred eeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhch
Q 018169 257 LVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESS 293 (360)
Q Consensus 257 ~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~ 293 (360)
+++++..+++|.|.|+++.+..++..-..-..+++..
T Consensus 9 ~~lar~l~~~~~G~~~~~~s~~~~~~~~~~~g~~~~~ 45 (251)
T PF13440_consen 9 ILLARYLGPEDFGIYALIFSIVSILSIVASLGLRQSL 45 (251)
T ss_pred HHHHHHCCHHHhHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3567888999999999999999988887655565543
No 35
>PF01943 Polysacc_synt: Polysaccharide biosynthesis protein; InterPro: IPR002797 Members of this family are integral membrane proteins [], and many are implicated in the production of polysaccharide. The family includes RfbX part of the O antigen biosynthesis operon [], and SpoVB from Bacillus subtilis (Q00758 from SWISSPROT), which is involved in spore cortex biosynthesis [].; GO: 0000271 polysaccharide biosynthetic process, 0016020 membrane
Probab=60.91 E-value=27 Score=31.44 Aligned_cols=63 Identities=14% Similarity=0.078 Sum_probs=44.6
Q ss_pred HHHHHHHHHHHHHHhhhceeeeEeccCCCcchhhhHhhhhhhHHHHHHHhhhhhchHHHHHhh
Q 018169 238 CTLFTFQSFRKLLLQEGEKLVLVWLDTPYNQAVYGLVDKLGSLVVRMVFLPFEESSYATFARS 300 (360)
Q Consensus 238 ~~~~~~qsi~k~lltegDk~vl~~~~~~~~qG~Y~la~nlgsl~aR~lf~Piee~~~~~Fs~~ 300 (360)
..|.+...+++.+..=.=..++++..++++.|.|+++.++.++..=..-.-++.+..-..++.
T Consensus 5 ~~~~~~~~~~~~~~~~~~~~il~r~l~~~~~G~~~~~~~~~~~~~~~~~~G~~~~~~r~~~~~ 67 (273)
T PF01943_consen 5 SLWLFLSNILSALIGFITIPILARYLGPEEYGIYSLALSIVSLLSILADLGLSQAIVRFIAEY 67 (273)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhCHHHhHHHHHHHHHHHHHHHHHhhhhHHHHHHHHHHh
Confidence 345555666666666666778888999999999999999998876555555655554444444
No 36
>PF14667 Polysacc_synt_C: Polysaccharide biosynthesis C-terminal domain
Probab=48.32 E-value=1.5e+02 Score=24.17 Aligned_cols=65 Identities=15% Similarity=0.123 Sum_probs=48.1
Q ss_pred HHHHHHHHHHHhhhhhHHHHHHHhHhHHHHHHHHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHH
Q 018169 129 IFINGFACVLELLAEPLYILSQNLLLLRLRLVVETVATFSRCFTMCILIVKQYEMEKGIVFALSQVAYA 197 (360)
Q Consensus 129 ~~~~~ls~iie~l~eP~~~~~qr~l~~~~r~~~E~~a~~~~~~~~v~l~~~~~~~~a~~~fa~gql~~s 197 (360)
+.+++++.++..+..|.....|-.-+.+...+....+.+++.+..+.+... ++..+.+++.....
T Consensus 2 l~il~~~~~~~~l~~~~~~il~~~~k~~~~~~~~~~~~~v~i~~~~~li~~----~G~~Gaa~a~~i~~ 66 (146)
T PF14667_consen 2 LQILALAIIFMGLSQPLGSILQAMGKTKWPFIITLIGAIVNIILNYILIPR----FGIYGAAIATAISE 66 (146)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHcCCchHHHHHHHHHHHHHHHHHHHHHHH----HHHhHHHHHHHHHH
Confidence 356788999999999998888887788888888888888888888776433 33444445555443
No 37
>COG0728 MviN Uncharacterized membrane protein, putative virulence factor [General function prediction only]
Probab=47.74 E-value=89 Score=32.62 Aligned_cols=115 Identities=9% Similarity=0.028 Sum_probs=70.1
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhceeeeEeccCC-CcchhhhHhhhhhhHHHHHHHhhh-hhchHHHHHhhhcCCCchhhh
Q 018169 233 QLANMCTLFTFQSFRKLLLQEGEKLVLVWLDTP-YNQAVYGLVDKLGSLVVRMVFLPF-EESSYATFARSASGQYPQKSK 310 (360)
Q Consensus 233 ~ll~~~~~~~~qsi~k~lltegDk~vl~~~~~~-~~qG~Y~la~nlgsl~aR~lf~Pi-ee~~~~~Fs~~~~~~~~~~~~ 310 (360)
.+++-...+..-.++.-++-=.-..+++...+. ..--.|.+|+.+=++.-|++-... ..+.=|.|++..+++.+++..
T Consensus 8 sllks~~~vs~~Tl~SRi~G~vRd~~iA~~fGa~~~aDAF~vAf~iPN~lRrlfaegafs~aFVPv~~~~~~~~~~~~~~ 87 (518)
T COG0728 8 SLLKSLIIVSSATLLSRILGFVRDVLIAAAFGAGAAADAFFVAFKLPNLLRRLFAEGAFSSAFVPVLAEAKKKEGEEAAR 87 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCchHHHHHHHHHHhHHHHHHHHhchhHhhhhhHHHHHHHHcchhhHHH
Confidence 344444444444444444433333445555543 555689999999999888887775 777788888887665333222
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhcccChHHHHHHHhcCCc
Q 018169 311 KIGNSLAEALKLVLLIGMFFIELKFSLPIYEFNFVVKGIC 350 (360)
Q Consensus 311 ~~~~~l~~~L~~~~~lgl~~~~~G~~~s~~ll~~llG~kW 350 (360)
+.++. ..-....+.+.....|..-+|.+++.++|+.|
T Consensus 88 ~f~~~---v~~~l~~~ll~vt~L~~l~~p~iv~~~~~~g~ 124 (518)
T COG0728 88 FFSRL---VTGLLTLVLLLVTLLGILFAPWLVRLLLAPGF 124 (518)
T ss_pred HHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 23332 22244444455555666668999999999987
No 38
>PF06123 CreD: Inner membrane protein CreD; InterPro: IPR010364 This family consists of several bacterial CreD or Cet inner membrane proteins. Dominant mutations of the cet gene of Escherichia coli result in tolerance to colicin E2 and increased amounts of an inner membrane protein with a Mr of 42,000. The cet gene is shown to be in the same operon as the phoM gene, which is required in a phoR background for expression of the structural gene for alkaline phosphatase, phoA. Although the Cet protein is not required for phoA expression, it has been suggested that the Cet protein has an enhancing effect on the transcription of phoA [].
Probab=38.35 E-value=4.3e+02 Score=26.97 Aligned_cols=60 Identities=25% Similarity=0.349 Sum_probs=44.4
Q ss_pred CCCcchhhhHHHHHHHHHHHHHHHHHHHHHHHHH-HhhChhhhHHHHHHHHHHHHHHHHHhH
Q 018169 5 PVDHSTSLSRTFKYLLATQFLSRGIPFVFNSWIV-RHLTEADYAIYAVQFHLFVTCVLFLSR 65 (360)
Q Consensus 5 ~~~~~~~~~~g~~~li~~q~~srlltF~~n~iL~-R~LsP~~fGi~av~l~l~~~tvlflsr 65 (360)
|++.=.+..|+..|-++.=.++= +.|.+--++. +.+.|=.|+++..++.+++...+.+|+
T Consensus 287 Pvd~Y~~~~Ra~KYgiLFI~LTF-~~fflfE~~~~~~iHpiQY~LVGlAl~lFYlLLLSlSE 347 (430)
T PF06123_consen 287 PVDHYQKSERAVKYGILFIGLTF-LAFFLFELLSKLRIHPIQYLLVGLALVLFYLLLLSLSE 347 (430)
T ss_pred cccHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHhcCcccHHHHHHHHHHHHHHHHHHHHHHh
Confidence 56666678999999877544444 4444444444 469999999999999998887777766
No 39
>PF12794 MscS_TM: Mechanosensitive ion channel inner membrane domain 1
Probab=36.46 E-value=4.2e+02 Score=25.91 Aligned_cols=30 Identities=7% Similarity=-0.008 Sum_probs=22.5
Q ss_pred hHHHHHHHHHHHHhhhhhHHHHHHHhHhHH
Q 018169 127 QAIFINGFACVLELLAEPLYILSQNLLLLR 156 (360)
Q Consensus 127 ~~~~~~~ls~iie~l~eP~~~~~qr~l~~~ 156 (360)
..+.+...-.++..+..=...+.+|++.++
T Consensus 232 ~sl~l~~~~~l~~~l~~Rwl~v~~RRLA~~ 261 (340)
T PF12794_consen 232 LSLYLLLGWLLVYQLILRWLLVARRRLAYE 261 (340)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 466777777788888888888888877654
No 40
>COG3628 Phage baseplate assembly protein W [General function prediction only]
Probab=35.29 E-value=16 Score=30.04 Aligned_cols=24 Identities=17% Similarity=0.209 Sum_probs=19.9
Q ss_pred hHhhhhhhHHHHHHHhhhhhchHH
Q 018169 272 GLVDKLGSLVVRMVFLPFEESSYA 295 (360)
Q Consensus 272 ~la~nlgsl~aR~lf~Piee~~~~ 295 (360)
-+=-||||...+++++|++++.+.
T Consensus 38 vmRp~yGs~L~~Lid~p~~~a~~~ 61 (116)
T COG3628 38 VMRPDYGSNLPRLIDQPINPALRS 61 (116)
T ss_pred ccccccccchHHHHhcccCHHHHH
Confidence 345799999999999999887653
No 41
>COG4452 CreD Inner membrane protein involved in colicin E2 resistance [Defense mechanisms]
Probab=22.57 E-value=7.3e+02 Score=25.03 Aligned_cols=56 Identities=21% Similarity=0.247 Sum_probs=36.7
Q ss_pred hhhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhChhhhHHHHHHHHHHHHHHHHHhH
Q 018169 10 TSLSRTFKYLLATQFLSRGIPFVFNSWIVRHLTEADYAIYAVQFHLFVTCVLFLSR 65 (360)
Q Consensus 10 ~~~~~g~~~li~~q~~srlltF~~n~iL~R~LsP~~fGi~av~l~l~~~tvlflsr 65 (360)
...-|+..|.++.=-.+=..-|+.-.+-.-.+.|-.|+++..++-+++-..|-+|+
T Consensus 292 q~~~RA~kYaIlfI~Ltf~afFifE~lt~~~~Hp~QY~LVGlsLv~FYLLLLaLsE 347 (443)
T COG4452 292 QLTDRATKYAILFIGLTFMAFFIFEVLTGQRLHPMQYLLVGLSLVMFYLLLLALSE 347 (443)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhhhhcccccchHHHHHHHHHHHHHHHHHHHHHh
Confidence 34567777776544333333444444444468999999999988888877666664
No 42
>PRK11715 inner membrane protein; Provisional
Probab=22.17 E-value=8.6e+02 Score=24.88 Aligned_cols=60 Identities=23% Similarity=0.358 Sum_probs=42.8
Q ss_pred CCCcchhhhHHHHHHHHHHHHHHHHHHHHHHHHHH-hhChhhhHHHHHHHHHHHHHHHHHhH
Q 018169 5 PVDHSTSLSRTFKYLLATQFLSRGIPFVFNSWIVR-HLTEADYAIYAVQFHLFVTCVLFLSR 65 (360)
Q Consensus 5 ~~~~~~~~~~g~~~li~~q~~srlltF~~n~iL~R-~LsP~~fGi~av~l~l~~~tvlflsr 65 (360)
|++.=.+.-|+..|-++.=.++ .+.|.+--++.+ .+.|=.|+++..++.+++...+.+|+
T Consensus 293 PVd~Y~~~~RA~KYgiLFI~LT-F~~fFlfE~~~~~~iHpiQYlLVGlAl~lFYLLLLSlSE 353 (436)
T PRK11715 293 PVDQYQKTERAVKYAILFIALT-FAAFFLFELLKKLRIHPVQYLLVGLALVLFYLLLLSLSE 353 (436)
T ss_pred cccHHHHHHHHHhHHHHHHHHH-HHHHHHHHHhcCceecHHHHHHHHHHHHHHHHHHHHHHh
Confidence 5555567788888886654443 444455555555 69999999999999988877777766
Done!